Ask OpenScientist

Ask a research question about OTUD6B-Related Neurodevelopmental Disorder. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
9
Pathophys.
34
Phenotypes
10
Pathograph
1
Genes
5
Medical Actions
4
Differentials
14
References
1
Deep Research
🏷

Classifications

Harrison's Chapter
NEUROLOGIC GENETICS_ENVIRONMENT_DISEASE
👪

Inheritance

1
Autosomal recessive inheritance HP:0000007
Disease requires biallelic (homozygous or compound heterozygous) OTUD6B variants. Reported families include consanguineous pedigrees with homozygous alleles and non-consanguineous pedigrees with compound heterozygous alleles. Heterozygous carrier parents are unaffected. Recurrence risk for siblings of an affected proband is 25 percent, and carrier testing plus genetic counseling are indicated for at-risk relatives.
Autosomal recessive inheritance
Show evidence (2 references)
PMID:35430327 SUPPORT Human Clinical
"an autosomal recessive multisystem disorder caused by compound heterozygous or homozygous variants in the gene OTUD6B"
Directly states the autosomal recessive, biallelic requirement, including both the homozygous and compound heterozygous configurations.
PMID:30364145 SUPPORT Human Clinical
"The segregation in the family was confirmed by Sanger sequencing: the father (I1) was carrier of the c.324+1G>C mutation whereas the mother (I2) was heterozygous for c.405+1G>A."
Documents biparental transmission of two different alleles to an affected compound heterozygous child, with unaffected heterozygous carrier parents.

Pathophysiology

9
Biallelic OTUD6B Loss-of-Function Variants
The disorder is initiated by inheritance of two damaging OTUD6B alleles. The reported allelic spectrum includes nonsense alleles, canonical splice-donor alleles that abolish normal splicing and trigger nonsense-mediated decay, frameshift alleles, and rare missense alleles within the catalytic OTU domain.
OTUD6B hgnc:24281
Show evidence (2 references)
PMID:28343629 SUPPORT Human Clinical
"we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6 independent families with an intellectual disability syndrome associated with seizures and dysmorphic features"
Establishes biallelic OTUD6B variants as the initiating genetic lesion in the original multi-family discovery cohort.
PMID:30364145 SUPPORT Human Clinical
"Data analysis highlighted the presence of two heterozygous variants affecting exons 2 (c.324+1G>C) and 3 (c.405+1G>A) donor splice sites of the OTUD6B gene"
An independent replication family in which two canonical splice-donor alleles constitute the biallelic lesion.
Loss of OTUD6B Deubiquitinase Activity
OTUD6B encodes a member of the ovarian tumor (OTU) domain subfamily of deubiquitinating enzymes, which remove ubiquitin from substrate proteins and thereby counterbalance E1/E2/E3 ubiquitin conjugation. Loss of this activity removes a node of control over ubiquitin-dependent protein turnover, trafficking, and signaling.
protein deubiquitination GO:0016579 ↓ DECREASED
cysteine-type deubiquitinase activity GO:0004843 ↓ DECREASED
Show evidence (2 references)
PMID:28343629 SUPPORT Human Clinical
"OTUD6B encodes a member of the ovarian tumor domain (OTU)-containing subfamily of deubiquitinating enzymes."
Identifies the molecular function lost when OTUD6B is disrupted.
PMID:33421002 PARTIAL In Vitro
"we study the protein-protein interaction between the two deubiquitinating enzymes OTUB1 and OTUD6B and report for the first time that both proteins directly interact with each other"
Places OTUD6B within the deubiquitinase interaction network. This is supporting context for the enzyme's role in ubiquitin signaling, not direct evidence about the disease, hence PARTIAL.
Allele-Dependent Residual OTUD6B Function
The severity of the clinical phenotype tracks the predicted functional severity of the specific OTUD6B alleles. Truncating and splice alleles that trigger nonsense-mediated decay give little or no product, whereas some missense alleles only locally destabilize the protein and others distort the overall fold. Molecular dynamics modeling of two OTU-domain missense alleles predicted localized destabilization for the allele found in a mildly affected individual and gross fold distortion for the allele found in a severely affected individual. In one replication family, residual wild-type splicing of under one percent, together with alleles that spare the short OTUD6B-2 isoform, was proposed to explain an unusually mild presentation.
Show evidence (3 references)
PMID:35430327 SUPPORT Computational
"it is anticipated that Tyr216Cys in the earlier reported case with less severe IDDFSDA will lead to localized destabilization, whereas Ile274Arg in the presented index case with the severe IDDFSDA phenotype will lead to significant distortion in the overall fold of OTUD6B"
Structural modeling and molecular dynamics link predicted protein-level damage to observed clinical severity for two OTU-domain missense alleles.
PMID:35430327 SUPPORT Computational
"our findings support that the clinical severity could be related with the predicted functional severity of the variations in OTUD6B"
States the genotype-severity relationship explicitly as the study's conclusion.
PMID:30364145 SUPPORT In Vitro
"we performed quantitative analysis by competitive-fluorescent RT-PCR showing that the proband presents less than 1% of the wild-type transcript"
Direct patient-RNA quantification of residual normal transcript, the measurable substrate of the residual-function idea.
Impaired 26S Proteasome Assembly
Peripheral blood mononuclear cells from an affected individual show reduced incorporation of 19S regulatory-particle subunits into 26S proteasomes. The mature 26S holoenzyme is formed by capping the 20S catalytic core with the 19S regulatory particle, so defective 19S incorporation reduces the pool of assembly-competent, ubiquitin-receptive proteasomes.
peripheral blood mononuclear cell CL:2000001
proteasome assembly GO:0043248 ↓ DECREASED
proteasome accessory complex (19S regulatory particle) GO:0022624
Show evidence (1 reference)
PMID:28343629 SUPPORT Human Clinical
"Analysis of peripheral blood mononuclear cells from an affected subject showed reduced incorporation of 19S subunits into 26S proteasomes"
Direct patient-cell measurement of the proteasome-assembly defect.
Reduced Proteasomal Chymotrypsin-Like Activity
Chymotrypsin-like peptidase activity, the rate-limiting catalytic activity of the 20S core, is decreased in patient peripheral blood mononuclear cells, indicating functionally reduced proteolytic throughput and not merely an assembly stoichiometry change.
proteasome-mediated ubiquitin-dependent protein catabolic process GO:0043161 ↓ DECREASED
proteasome complex GO:0000502
Show evidence (1 reference)
PMID:28343629 SUPPORT Human Clinical
"decreased chymotrypsin-like activity"
Reports the specific reduction of proteasome chymotrypsin-like peptidase activity in cells from an affected individual.
Accumulation of Ubiquitin-Protein Conjugates
Polyubiquitinated proteins accumulate in patient cells, the expected consequence of a reduced-capacity ubiquitin-proteasome system. This is the proteostatic lesion that the developing organism must tolerate.
ubiquitin-dependent protein catabolic process GO:0006511 ↓ DECREASED
Show evidence (2 references)
PMID:28343629 SUPPORT Human Clinical
"accumulation of ubiquitin-protein conjugates"
Patient-cell demonstration that undegraded ubiquitin conjugates build up when OTUD6B is lost.
PMID:28343629 SUPPORT Human Clinical
"Our findings suggest a role for OTUD6B in proteasome function, establish that defective OTUD6B function underlies a multisystemic human disorder"
The authors' own synthesis tying the proteasome defect to the multisystem human phenotype.
Dysregulated mTORC1-Linked Translation Initiation
Independently of the proteasome arm, OTUD6B regulates protein synthesis downstream of mTORC1. It associates with the protein synthesis initiation complex and modifies components of the 48S preinitiation complex, and its two main splicing isoforms act in opposing directions, with the long OTUD6B-1 isoform inhibitory and the short OTUD6B-2 isoform stimulatory. This work was performed in non-small cell lung cancer cell lines rather than in neural tissue, so its relevance to the human developmental phenotype is inferential.
regulation of translation GO:0006417 ⚠ ABNORMAL
Show evidence (2 references)
PMID:27864334 PARTIAL In Vitro
"evidence is presented that the deubiquitinase OTUD6B regulates protein synthesis in non-small cell lung cancer (NSCLC) cells, operating downstream from mTORC1"
Establishes the translation-regulatory function of OTUD6B. Marked PARTIAL because the experiments are in a cancer cell line, not in a disease-relevant developmental model.
PMID:27864334 PARTIAL In Vitro
"OTUD6B associates with the protein synthesis initiation complex and modifies components of the 48S preinitiation complex."
Identifies the specific molecular target of OTUD6B in the translation initiation machinery.
Impaired Cell Growth and Proliferation
Both the proteostatic arm and the translational arm converge on reduced growth and proliferative capacity. In cell models the two OTUD6B isoforms have opposing effects on DNA synthesis, so loss of the balanced isoform pair perturbs proliferation control rather than simply slowing it.
cell population proliferation GO:0008283 ⚠ ABNORMAL growth GO:0040007 ↓ DECREASED
Show evidence (1 reference)
PMID:27864334 PARTIAL In Vitro
"These properties affect NSCLC cell proliferation, because OTUD6B-1 represses DNA synthesis while OTUD6B-2 promotes it."
Demonstrates that OTUD6B isoform balance controls proliferation. PARTIAL because the model system is a cancer cell line.
Disrupted Embryonic Organogenesis and Growth
The organism-level convergence node. Reduced proliferative and biosynthetic capacity during embryogenesis produces prenatal-onset growth restriction, microcephaly and structural brain malformation, congenital heart defects, and the distal limb and craniofacial patterning anomalies that define the syndrome. Homozygous Otud6b knockout mice recapitulate the severe end of this spectrum, being subviable and small with congenital heart defects.
heart development GO:0007507 ⚠ ABNORMAL
Show evidence (2 references)
PMID:28343629 SUPPORT Model Organism
"Homozygous Otud6b knockout mice were subviable, smaller in size, and had congenital heart defects, consistent with the severity of loss-of-function variants in humans."
An orthologous null mouse reproduces the growth restriction and congenital heart disease seen at the severe end of the human spectrum, supporting a developmental-organogenesis mechanism.
PMID:28343629 SUPPORT Human Clinical
"growth retardation with prenatal onset, feeding difficulties, structural brain abnormalities, congenital malformations including congenital heart disease, and musculoskeletal features"
The human multisystem malformation and growth phenotype that this node represents.

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for OTUD6B-Related Neurodevelopmental Disorder Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.

Phenotypes

34
Blood 1
Hypogammaglobulinemia Decreased circulating immunoglobulin concentration HP:0004313
Show evidence (1 reference)
PMID:32924626 SUPPORT Human Clinical
"the third patient with associated hypothyroidism and hypogammaglobulinemia"
Reports hypogammaglobulinemia recurring in a third unrelated affected individual.
Cardiovascular 1
Congenital Heart Disease FREQUENT Abnormal heart morphology HP:0001627
Frequency derivation: phenotype.hpoa annotates the specific cardiac lesions for OMIM:617452 against a cardiac-evaluated denominator of 6, giving atrial septal defect 3/6 (50 percent) and ventricular septal defect 2/6 (33 percent), both curated from PMID:28343629. Either maps to the FREQUENT band (30-79 percent), so FREQUENT is applied to the parent cardiac term. Note the denominator is 6, not the 12 used for the neurological terms, because only a subset of the founding cohort had cardiac assessment reported.
Show evidence (3 references)
PMID:28343629 SUPPORT Human Clinical
"congenital malformations including congenital heart disease, and musculoskeletal features"
Reports congenital heart disease among the malformations in affected humans.
PMID:28343629 SUPPORT Model Organism
"Homozygous Otud6b knockout mice were subviable, smaller in size, and had congenital heart defects"
The orthologous null mouse independently supports a causal role for OTUD6B loss in congenital heart defects.
PMID:35707595 SUPPORT Human Clinical
"we report one additional case with Tetralogy of Fallot (ToF), who has microcephaly and dysmorphic features along with renal parenchymal disease with simple cortical cysts"
Extends the cardiac phenotype beyond septal defects to a conotruncal malformation in a genetically confirmed individual. The renal cystic disease in the same proband is attributed by the authors to a separate PKD1 variant and is therefore not curated as an OTUD6B feature here.
Digestive 1
Feeding Difficulties FREQUENT Feeding difficulties HP:0011968
Frequency derivation: phenotype.hpoa annotates HP:0011968 Feeding difficulties for OMIM:617452 at 9/12 (75 percent), curated from PMID:28343629. That maps to the FREQUENT band (30-79 percent).
Show evidence (1 reference)
PMID:28343629 SUPPORT Human Clinical
"growth retardation with prenatal onset, feeding difficulties, structural brain abnormalities"
Feeding difficulties are reported in the loss-of-function subgroup.
Endocrine 1
Hypothyroidism Hypothyroidism HP:0000821
Show evidence (2 references)
PMID:32924626 SUPPORT Human Clinical
"this is the third patient with associated hypothyroidism and hypogammaglobulinemia, underscoring the value of screening for these conditions in other patients"
Identifies hypothyroidism recurring across at least three unrelated affected individuals.
PMID:41188742 SUPPORT Human Clinical
"A 6-month-old girl presented with nystagmus and hypothyroidism."
A further independent case of hypothyroidism in a genetically confirmed individual.
Eye 1
Nystagmus Nystagmus HP:0000639
Show evidence (1 reference)
PMID:41188742 SUPPORT Human Clinical
"A 6-month-old girl presented with nystagmus and hypothyroidism."
Reports nystagmus as the presenting ocular sign in a genetically confirmed case.
Head and Neck 5
Dysmorphic Facial Features Abnormal facial shape HP:0001999
Show evidence (1 reference)
PMID:38389298 SUPPORT Human Clinical
"Physical differences described for affected individuals suggest that the disorder may be clinically recognizable, but previous publications have reported an initial clinical suspicion for Kabuki syndrome (KS) in some affected individuals."
Establishes a recognizable dysmorphic facial phenotype and documents the clinically important Kabuki syndrome overlap.
Long Palpebral Fissures FREQUENT Long palpebral fissure HP:0000637
Frequency derivation: phenotype.hpoa annotates HP:0000637 Long palpebral fissure for OMIM:617452 at 6/12 (50 percent), curated from PMID:28343629. That maps to the FREQUENT band (30-79 percent).
Show evidence (1 reference)
PMID:38389298 SUPPORT Human Clinical
"clinical manifestations such as long palpebral fissures, prominent and cupped ears, developmental delay, growth deficiency, persistent fetal fingertip pads, vertebral anomaly, and seizures in the proband"
Names long palpebral fissures in three siblings with biallelic OTUD6B variants.
Long Philtrum Long philtrum HP:0000343
No frequency band is asserted. phenotype.hpoa does carry long philtrum at 7/12 for OMIM:617452 from PMID:28343629, which would map to FREQUENT, but the snippet cited here is the single-proband PMID:34680978 sentence rather than the cohort count, so the band is omitted rather than attributed to a source this entry does not quote. Same ZMIZ1 attribution caveat as Periorbital Edema applies to the PMID:34680978 observation itself.
Show evidence (1 reference)
PMID:34680978 PARTIAL Human Clinical
"We suggest that Williams syndrome-like phenotypes, namely, periorbital edema, hanging cheek, and long and smooth philtrum represent expanded phenotypes of OTUD6B-related ID."
Author-asserted phenotypic expansion naming a long philtrum. PARTIAL because the proband also carries a ZMIZ1 splice variant, though the independent HPOA annotation of long philtrum at 7/12 for OMIM:617452 makes this the best-corroborated member of the Williams-like triad.
Microcephaly FREQUENT Microcephaly HP:0000252
Frequency derivation: phenotype.hpoa annotates HP:0000252 Microcephaly for OMIM:617452 at 9/12 (75 percent), curated from PMID:28343629. That maps to the FREQUENT band (30-79 percent).
Show evidence (1 reference)
PMID:28343629 SUPPORT Human Clinical
"In subjects with predicted loss-of-function alleles, additional features include global developmental delay, microcephaly, absent speech, hypotonia"
Microcephaly is listed among the features of the loss-of-function subgroup.
Abnormally Shaped Teeth Abnormal dental morphology HP:0006482
Show evidence (1 reference)
PMID:34354232 SUPPORT Human Clinical
"macrodontia, dental crowding, abnormally shaped teeth, and thick alveolar ridges"
Directly reports abnormally shaped teeth.
Integument 2
Persistent Fetal Fingertip Pads Prominent fingertip pads HP:0001212
Show evidence (2 references)
PMID:38389298 SUPPORT Human Clinical
"growth deficiency, persistent fetal fingertip pads, vertebral anomaly, and seizures in the proband"
Directly reports persistent fetal fingertip pads in affected siblings.
PMID:34354232 SUPPORT Human Clinical
"Broad distal phalanges (especially the thumbs and halluces) with prominent interphalangeal joints and fetal pads were recognized in all patients and hence considered pathognomonic."
Independent report of fetal pads in all five patients of two Egyptian families.
Reduced Sweating Hypohidrosis HP:0000966
Show evidence (1 reference)
PMID:38389298 SUPPORT Human Clinical
"soft doughy skin with reduced sweating, and mirror movements"
Directly reports reduced sweating.
Limbs 2
Broad Distal Phalanges FREQUENT Broad thumb HP:0011304
Frequency derivation: phenotype.hpoa annotates HP:0011304 Broad thumb for OMIM:617452 at 6/12 (50 percent), curated from PMID:28343629. That maps to the FREQUENT band (30-79 percent). The HPO disease annotation uses the thumb term, which is also the digit the primary reports single out, so that term is bound here; the halluces are affected in parallel but are not separately annotated in HPOA.
Show evidence (1 reference)
PMID:34354232 SUPPORT Human Clinical
"Broad distal phalanges (especially the thumbs and halluces) with prominent interphalangeal joints and fetal pads were recognized in all patients and hence considered pathognomonic."
Reports broad distal phalanges of thumbs and halluces in all patients studied.
Polydactyly Polydactyly HP:0010442
Show evidence (1 reference)
PMID:34680978 PARTIAL Human Clinical
"The patient also had terminal broadening of the fingers and polydactyly."
Reports polydactyly with terminal digital broadening. Marked PARTIAL because this proband also carries a heterozygous ZMIZ1 c.1491 + 2T > C splice variant that skips exon 14, so attribution of the limb finding to OTUD6B alone is not secure. See the ZMIZ1 entry (MONDO:0032855) in differential_diagnoses.
Musculoskeletal 2
Hypotonia FREQUENT Generalized hypotonia HP:0001290
Frequency derivation: phenotype.hpoa annotates HP:0001290 Generalized hypotonia for OMIM:617452 at 9/12 (75 percent), curated from PMID:28343629. That maps to the FREQUENT band (30-79 percent). The generalized term is used here to match the HPO disease annotation.
Show evidence (1 reference)
PMID:28343629 SUPPORT Human Clinical
"global developmental delay, microcephaly, absent speech, hypotonia, growth retardation with prenatal onset"
Hypotonia is listed among the features of individuals with loss-of-function alleles.
Vertebral Anomalies Abnormal vertebral morphology HP:0003468
Show evidence (1 reference)
PMID:38389298 SUPPORT Human Clinical
"persistent fetal fingertip pads, vertebral anomaly, and seizures in the proband"
Reports a vertebral anomaly in the proband of the three-sibling family.
Nervous System 4
Global Developmental Delay Global developmental delay HP:0001263
Show evidence (1 reference)
PMID:28343629 SUPPORT Human Clinical
"In subjects with predicted loss-of-function alleles, additional features include global developmental delay, microcephaly, absent speech, hypotonia"
Lists global developmental delay among the features of individuals with loss-of-function alleles.
Intellectual Disability VERY_FREQUENT Intellectual disability HP:0001249
Frequency derivation: phenotype.hpoa annotates HP:0010864 Severe intellectual disability for OMIM:617452 at 12/12 (100 percent), curated from PMID:28343629, supporting a VERY_FREQUENT band (80-100 percent) for intellectual disability as such. This entry deliberately binds the broader HP:0001249 rather than the severe-ID term, because the 12/12 severity annotation reflects the ascertainment-biased 2017 cohort and is contradicted by later mild cases (PMID:30364145, PMID:34354232).
Show evidence (2 references)
PMID:28343629 SUPPORT Human Clinical
"an intellectual disability syndrome associated with seizures and dysmorphic features"
Intellectual disability is the anchoring feature named in the original gene-disease report.
PMID:30364145 SUPPORT Human Clinical
"At the latest neurological evaluation, at 6 years of age, she has mild intellectual disability, mild motor difficulty, and episodic behavioral disorders."
Documents the mild end of the intellectual disability spectrum in a replication case.
Seizures VERY_FREQUENT Seizure HP:0001250
Frequency derivation: phenotype.hpoa annotates HP:0001250 Seizure for OMIM:617452 at 12/12 (100 percent), curated from PMID:28343629. That maps to the VERY_FREQUENT band (80-100 percent).
Show evidence (2 references)
PMID:28343629 SUPPORT Human Clinical
"an intellectual disability syndrome associated with seizures and dysmorphic features"
Seizures are named as a core feature of the syndrome in the discovery cohort.
PMID:30364145 SUPPORT Human Clinical
"At 5 years, tonic-clonic seizures occurred, thus valproate treatment was started."
Documents generalized tonic-clonic semiology and childhood onset in an individual with biallelic OTUD6B splice variants.
Absent Speech Absent speech HP:0001344
Show evidence (1 reference)
PMID:28343629 SUPPORT Human Clinical
"additional features include global developmental delay, microcephaly, absent speech, hypotonia"
Absent speech is reported in the loss-of-function subgroup.
Growth 1
Prenatal-Onset Growth Restriction FREQUENT Intrauterine growth retardation HP:0001511
Frequency derivation: phenotype.hpoa annotates HP:0001511 Intrauterine growth retardation for OMIM:617452 at 7/12 (58 percent), curated from PMID:28343629. That maps to the FREQUENT band (30-79 percent).
Show evidence (2 references)
PMID:28343629 SUPPORT Human Clinical
"hypotonia, growth retardation with prenatal onset, feeding difficulties"
Explicitly reports growth retardation with prenatal onset.
PMID:38389298 SUPPORT Human Clinical
"developmental delay, growth deficiency, persistent fetal fingertip pads"
Independent confirmation of growth deficiency in a second family.
Other 13
Cupped Ears Cupped ear HP:0000378
Show evidence (1 reference)
PMID:38389298 SUPPORT Human Clinical
"long palpebral fissures, prominent and cupped ears"
Directly reports prominent and cupped ears in affected siblings.
Periorbital Edema Periorbital edema HP:0100539
Attribution caveat. This observation comes from the single proband of PMID:34680978, who carries both a hemizygous OTUD6B c.873delA allele in trans with a paternally inherited 0.118 Mb 8q21.3 whole-gene deletion AND a heterozygous ZMIZ1 splice variant, c.1491 + 2T > C, shown by mRNA study to skip exon 14. ZMIZ1 causes its own autosomal dominant neurodevelopmental disorder with dysmorphic facies (MONDO:0032855), which is recorded in this entry's differential_diagnoses, so the facial gestalt in this proband cannot be attributed to OTUD6B alone. The authors themselves only "suggest" the expansion. Curated with supports PARTIAL for that reason. No frequency band is given: this is a single case with no denominator.
Show evidence (1 reference)
PMID:34680978 PARTIAL Human Clinical
"We suggest that Williams syndrome-like phenotypes, namely, periorbital edema, hanging cheek, and long and smooth philtrum represent expanded phenotypes of OTUD6B-related ID."
Author-asserted phenotypic expansion naming periorbital edema. PARTIAL because the proband also carries a ZMIZ1 exon-14-skipping splice variant and the authors frame the attribution as a suggestion rather than an established finding.
Hanging Cheek Abnormal cheek morphology HP:0004426
Ontology gap. HPO has no term for "hanging cheek". HP:0034273 Premature sagging cheeks is defined as sagging beyond that expected for age and HP:0000293 Full cheeks describes increased fullness, neither of which is what the authors describe, so this is bound to the immediate parent HP:0004426 Abnormal cheek morphology with the published wording kept in preferred_term. Same attribution caveat as Periorbital Edema: the single PMID:34680978 proband also carries a heterozygous ZMIZ1 c.1491 + 2T > C splice variant that skips exon 14, and ZMIZ1-related disorder (MONDO:0032855, in this entry's differential_diagnoses) itself causes dysmorphic facies, so attribution to OTUD6B alone is not secure.
Show evidence (1 reference)
PMID:34680978 PARTIAL Human Clinical
"We suggest that Williams syndrome-like phenotypes, namely, periorbital edema, hanging cheek, and long and smooth philtrum represent expanded phenotypes of OTUD6B-related ID."
Author-asserted phenotypic expansion naming hanging cheek. PARTIAL because of the co-occurring ZMIZ1 splice variant in the same proband and the authors' own hedged framing.
Smooth Philtrum Smooth philtrum HP:0000319
Curated separately from Long Philtrum because HPO codes philtral length (HP:0000343) and philtral depth (HP:0000319) as distinct terms, and the source sentence asserts both. Unlike long philtrum, smooth philtrum has no corroborating HPOA annotation for OMIM:617452, so it rests entirely on this one proband, who also carries the heterozygous ZMIZ1 c.1491 + 2T > C variant.
Show evidence (1 reference)
PMID:34680978 PARTIAL Human Clinical
"We suggest that Williams syndrome-like phenotypes, namely, periorbital edema, hanging cheek, and long and smooth philtrum represent expanded phenotypes of OTUD6B-related ID."
Author-asserted phenotypic expansion naming a smooth philtrum. PARTIAL because it is a single-proband observation confounded by a co-occurring ZMIZ1 exon-14-skipping variant.
Structural Brain Abnormalities Abnormal brain morphology HP:0012443
Show evidence (2 references)
PMID:28343629 SUPPORT Human Clinical
"feeding difficulties, structural brain abnormalities, congenital malformations including congenital heart disease"
Reports structural brain abnormalities as part of the multisystem phenotype.
PMID:34354232 SUPPORT Human Clinical
"our patients showed inter- and intrafamilial differences with regard to the clinical and brain imaging findings"
Documents variability of the brain imaging phenotype within and between OTUD6B families.
Prominent Interphalangeal Joints Prominent interphalangeal joints HP:0006237
Show evidence (1 reference)
PMID:34354232 SUPPORT Human Clinical
"Broad distal phalanges (especially the thumbs and halluces) with prominent interphalangeal joints and fetal pads"
Directly reports prominent interphalangeal joints as part of the distal limb phenotype.
Macrodontia Macrodontia HP:0001572
Show evidence (1 reference)
PMID:34354232 SUPPORT Human Clinical
"various orodental features were present including macrodontia, dental crowding, abnormally shaped teeth, and thick alveolar ridges"
Directly reports macrodontia in the Egyptian OTUD6B cohort.
Dental Crowding Dental crowding HP:0000678
Show evidence (1 reference)
PMID:34354232 SUPPORT Human Clinical
"including macrodontia, dental crowding, abnormally shaped teeth, and thick alveolar ridges"
Directly reports dental crowding.
Delayed Eruption of Primary Teeth Delayed eruption of primary teeth HP:0000680
Show evidence (1 reference)
PMID:38389298 SUPPORT Human Clinical
"previously unreported clinical manifestations such as delayed eruption of primary dentition, soft doughy skin with reduced sweating, and mirror movements present in our patients suggest an expansion of the phenotype"
Reports delayed eruption of primary dentition as a phenotype-expanding finding.
Mirror Movements Bimanual synkinesia HP:0001335
Show evidence (1 reference)
PMID:38389298 SUPPORT Human Clinical
"delayed eruption of primary dentition, soft doughy skin with reduced sweating, and mirror movements present in our patients suggest an expansion of the phenotype"
Reports mirror movements as a newly described feature in OTUD6B-related disease.
Soft Doughy Skin Soft skin HP:0000977
Show evidence (1 reference)
PMID:38389298 SUPPORT Human Clinical
"soft doughy skin with reduced sweating"
Directly reports soft doughy skin.
Optic Disc Hypoplasia and Ocular Developmental Anomalies VERY_RARE Optic disc hypoplasia HP:0007766
Frequency derivation: PMID:41188742 states that none of the 27 previously reported IDDFSDA cases exhibited ocular developmental abnormalities, and reports one new case with them. That gives 1 of 28 reported individuals (approximately 3.6 percent), which maps to the VERY_RARE band (1-4 percent). This is the only phenotype in this entry with a published denominator; all others omit a frequency band deliberately.
Show evidence (2 references)
PMID:41188742 SUPPORT Human Clinical
"On admission, optic disc hypoplasia and retinal abnormalities were detected with a typical phenotype of IDDFSDA."
Reports optic disc hypoplasia and retinal abnormalities in a genetically confirmed individual.
PMID:41188742 PARTIAL Human Clinical
"Significantly, none of the 27 previously reported IDDFSDA cases exhibited ocular developmental abnormalities."
Supplies the denominator for the VERY_RARE band and simultaneously flags that the association rests on a single observation.
Retinal Degeneration Retinal degeneration HP:0000546
Show evidence (2 references)
PMID:34354232 REFUTE Human Clinical
"Retinal degeneration, albeit present in both patients from Family I, was shown to be unrelated to OTUD6B, demonstrating the need for in-depth analysis of WES data in consanguineous families to uncover simultaneous autosomal recessive disorders."
Explicitly refutes retinal degeneration as part of the OTUD6B phenotype and attributes it to a second, independent recessive disorder in the same family.
PMID:34354232 REFUTE Human Clinical
"Biallelic pathogenic variants in RP1L1 cause autosomal recessive retinitis pigmentosa type 88 (RP88). Thus, RP1L1 dysfunction likely accounts for the visual phenotype in this family"
Names the alternative causal gene, closing the loop on the exclusion.
🧬

Genetic Associations

1
OTUD6B biallelic pathogenic variants (Biallelic pathogenic variants are causative for IDDFSDA)
Gene: OTUD6B hgnc:24281 relationship_type: CAUSATIVE variant_origin: GERMLINE
Autosomal recessive inheritance
Show evidence (7 references)
PMID:28343629 SUPPORT Human Clinical
"we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6 independent families with an intellectual disability syndrome associated with seizures and dysmorphic features"
The gene-disease-establishing multi-family cohort.
PMID:34354232 SUPPORT Human Clinical
"Whole-exome sequencing (WES) identified a novel nonsense variant in OTUD6B (c.271C>T, p.(Gln91Ter))"
Documents a specific nonsense allele identified by exome sequencing.
PMID:34354232 SUPPORT Human Clinical
"In Family II, targeted sequencing revealed a novel homozygous missense variant (c.767G>T, p.(Gly256Val)), confirming the clinically suspected OTUD6B-related ID."
Documents a homozygous OTU-domain missense allele.
+ 4 more references
💊

Medical Actions

5
Antiseizure Pharmacotherapy
Action: Pharmacotherapy NCIT:C15986
Agent: valproic acid CHEBI:39867
Seizures are managed with standard antiseizure medication. Valproate was used to treat generalized tonic-clonic seizures in a reported individual with biallelic OTUD6B splice variants. There is no disorder-specific antiseizure protocol and no evidence that any particular agent is preferred in OTUD6B-related disease; drug choice follows general pediatric epilepsy practice and seizure semiology.
Show evidence (1 reference)
PMID:30364145 SUPPORT Human Clinical
"At 5 years, tonic-clonic seizures occurred, thus valproate treatment was started."
Documents actual antiseizure pharmacotherapy in a genetically confirmed individual.
Levothyroxine Replacement for Hypothyroidism
Action: Pharmacotherapy NCIT:C15986
Agent: levothyroxine CHEBI:18332
Hypothyroidism recurs in unrelated affected individuals and is the one genuinely treatable manifestation of this disorder, which is why endocrine surveillance is recommended in the first place. Standard thyroid hormone replacement is used; nothing about the OTUD6B genotype changes the drug or the monitoring. In the reported Chinese case, levothyroxine was started in the week the newborn metabolic screen returned, and by 3 years 6 months the dose had been titrated down with thyroid function in the normal range on every check, so this is a treatment with a documented biochemical response in a genetically confirmed individual.
Show evidence (2 references)
PMID:41188742 SUPPORT Human Clinical
"She started levothyroxine sodium tablets that same week."
Documents actual levothyroxine therapy in a genetically confirmed individual with OTUD6B-related hypothyroidism.
PMID:41188742 SUPPORT Human Clinical
"At her last visit, age 3 years 6 months, the dose was down to 12.5 µg daily, with every thyroid check since 3monts age within the normal range."
Records the biochemical response and dose titration on follow-up. Quoted verbatim from the cached full text including its typographic artifacts ("3monts"), per the never-retype rule.
Endocrine and Immunologic Surveillance
Action: Supportive Care NCIT:C15747
Because hypothyroidism and hypogammaglobulinemia have recurred in unrelated affected individuals and both are treatable, thyroid function testing and immunoglobulin quantification are recommended at diagnosis and on follow-up.
Show evidence (1 reference)
PMID:32924626 SUPPORT Human Clinical
"the third patient with associated hypothyroidism and hypogammaglobulinemia, underscoring the value of screening for these conditions in other patients"
The authors explicitly recommend screening for these two treatable comorbidities in other affected individuals.
Multidisciplinary Supportive Care
Action: Supportive Care NCIT:C15747
Management is supportive and symptom-directed: seizure control, nutritional and feeding support for poor growth and feeding difficulty, developmental and rehabilitative therapies, cardiac evaluation for congenital heart disease, and dental care for the orodental phenotype. There is no disease-modifying therapy.
Show evidence (2 references)
PMID:32924626 SUPPORT Human Clinical
"The current challenge with this patient is to ensure medical management of his seizures and provide him with a better quality of life."
Characterizes present-day management as symptomatic and quality-of-life focused rather than disease-modifying.
PMID:32924626 PARTIAL Human Clinical
"The possibilities of additional therapeutic approaches may increase by understanding the physiopathology of the involved pathways."
States that mechanism-targeted therapy does not yet exist and remains aspirational.
Genetic Counseling and Carrier Testing
Action: Genetic Counseling NCIT:C15240
Autosomal recessive inheritance gives a 25 percent sibling recurrence risk. Counseling should cover the recessive model, carrier testing of parents and at-risk relatives, and the option of prenatal or preimplantation testing once the familial variants are known. Consanguinity is common in reported families, and the RP1L1 experience in PMID:34354232 shows that a second independent recessive disorder can co-segregate and confound the phenotype, so exome or genome data should be reanalyzed in depth in consanguineous pedigrees.
Show evidence (1 reference)
PMID:34354232 SUPPORT Human Clinical
"demonstrating the need for in-depth analysis of WES data in consanguineous families to uncover simultaneous autosomal recessive disorders"
Directly supports the counseling and reanalysis recommendation for consanguineous families.
🔀

Differential Diagnoses

4

Conditions with similar clinical presentations that must be differentiated from OTUD6B-Related Neurodevelopmental Disorder:

BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies Not Yet Curated MONDO:0060596
Overlapping Features A distinct autosomal dominant entity (MONDO:0060596, OMIM:617755) caused by heterozygous variants in BPTF (hgnc:3581). Its MONDO label differs from this disorder's by two words, which makes it the single most likely entity to be conflated with OTUD6B disease in a text or label-based search.
Distinguishing Features
  • Molecular: BPTF (hgnc:3581) heterozygous, autosomal dominant and typically de novo, versus OTUD6B (hgnc:24281) biallelic and autosomal recessive. The inheritance mode alone separates them in almost every family.
  • Nomenclature: the near-identical MONDO labels are the hazard, not the phenotypes. Confirm the causative gene before importing any cohort data published under the "dysmorphic facies and distal limb anomalies" phrasing.
Show evidence (1 reference)
PMID:33522091 SUPPORT Human Clinical
"Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies (NEDDFL), defined primarily by developmental delay/intellectual disability, speech delay, postnatal microcephaly, and dysmorphic features, is a syndrome resulting from heterozygous variants in the dosage-sensitive..."
Establishes in the source's own words that the near-identically labelled NEDDFL entity is caused by heterozygous BPTF variants, which is the molecular discriminator this differential turns on.
ZMIZ1-related neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies Not Yet Curated MONDO:0032855
Overlapping Features A distinct autosomal dominant entity (MONDO:0032855, OMIM:618659) caused by heterozygous variants in ZMIZ1 (hgnc:16493). Its label differs from this disorder's only in "skeletal" versus "limb". This is not only a label hazard: PMID:34680978 reports a proband who genuinely carries variants in both genes, so the two entities can co-occur in one patient.
Distinguishing Features
  • Molecular: ZMIZ1 (hgnc:16493) heterozygous and autosomal dominant, versus biallelic recessive OTUD6B. ZMIZ1 is a transcriptional coregulator, not a deubiquitinase, so there is no shared mechanism to justify pooling evidence.
  • Co-occurrence, not just confusion: in PMID:34680978 the same 5-year-old girl carries a hemizygous OTUD6B c.873delA over a paternal 8q21.3 whole-gene deletion AND a heterozygous ZMIZ1 c.1491 + 2T > C splice variant confirmed by mRNA study to skip exon 14. Her Williams syndrome-like facial features (periorbital edema, hanging cheek, long and smooth philtrum) and her polydactyly are curated in this entry with supports PARTIAL for exactly this reason. Finding a ZMIZ1 variant therefore does not exclude OTUD6B disease, and vice versa.
Show evidence (3 references)
PMID:34680978 SUPPORT Human Clinical
"The OTUD6B and ZMIZ1 genes were recently identified as causes of syndromic intellectual disability (ID) with shared phenotypes of facial dysmorphism, distal limb anomalies, and seizure disorders."
States the phenotypic overlap that makes ZMIZ1 a differential for this disorder, in the authors' own words.
PMID:34680978 SUPPORT Human Clinical
"OTUD6B- and ZMIZ1-related ID are inherited in autosomal recessive and autosomal dominant patterns, respectively."
Sources the inheritance-mode discriminator that separates the two entities in nearly every family.
PMID:34680978 SUPPORT Human Clinical
"This ZMIZ1 variant yielded exon 14 skipping, as evidenced by mRNA study."
Functional confirmation that the second-locus ZMIZ1 allele in this proband is real and consequential, which is what makes it a genuine confounder for the facial phenotypes rather than an incidental finding.
OTUD5-related multiple congenital anomalies syndrome Not Yet Curated MONDO:0025351
Overlapping Features An X-linked disorder (MONDO:0025351, OMIM:301056) caused by hemizygous variants in OTUD5 (hgnc:25402), confirmed against the MONDO `RO:0004003` gene-association relation. OTUD5 is a member of the same OTU deubiquitinase family as OTUD6B, so the two share ubiquitin-signalling mechanism language and are frequently co-discussed in reviews of OTU-family disease.
Distinguishing Features
  • Molecular: X-linked hemizygous OTUD5 in males, versus autosomal recessive biallelic OTUD6B in either sex.
  • Literature hazard: papers about "OTU deubiquitinase deficiency" may describe either gene. Check which gene the reported cohort actually carries variants in before citing it here.
OTUD7A-related phenotypes and the 15q13.3 microdeletion syndrome Not Yet Curated MONDO:0012774
Overlapping Features OTUD7A lies within the 15q13.3 microdeletion critical region and is another OTU-family gene implicated in neurodevelopmental disease, so it appears alongside OTUD6B in family-level reviews.
Distinguishing Features
  • Molecular: a recurrent copy-number loss at 15q13.3 detected by chromosomal microarray, versus biallelic OTUD6B sequence variants detected by exome or gene-panel sequencing. Different assay, different mechanism.
{ }

Source YAML

click to show
name: OTUD6B-Related Neurodevelopmental Disorder
creation_date: "2026-08-01T00:00:00Z"
category: Mendelian
description: >-
  OTUD6B-related neurodevelopmental disorder (intellectual developmental disorder
  with dysmorphic facies, seizures, and distal limb anomalies; IDDFSDA, MIM 617452)
  is an ultra-rare autosomal recessive multisystem disorder caused by biallelic
  variants in OTUD6B, which encodes an ovarian-tumor (OTU) domain deubiquitinating
  enzyme. The core clinical picture is global developmental delay and intellectual
  disability with seizures, a recognizable dysmorphic facial gestalt, poor pre- and
  postnatal growth, and characteristic distal limb findings (broad distal phalanges
  of thumbs and halluces, prominent interphalangeal joints, persistent fetal
  fingertip pads). Individuals with predicted loss-of-function alleles are more
  severely affected, with microcephaly, absent speech, hypotonia, feeding
  difficulties, structural brain abnormalities, and congenital heart disease;
  individuals carrying alleles with residual function can have mild to moderate
  intellectual disability with preserved speech and ambulation. Mechanistically,
  patient cells show reduced incorporation of 19S regulatory subunits into 26S
  proteasomes, decreased chymotrypsin-like proteasome activity, and accumulation
  of ubiquitin-protein conjugates, placing the disorder among the ubiquitin-proteasome
  system disorders of development.
notes: >-
  Named-entity-confusion guardrail. This entry is anchored strictly on
  MONDO:0044319 / OMIM:617452 / OTUD6B (HGNC:24281), confirmed by the MONDO
  `RO:0004003` gene-association relation. It is deliberately NOT merged with
  three closely named or closely related entities. (1) MONDO:0060596
  "neurodevelopmental disorder with dysmorphic facies and distal limb
  anomalies" is the BPTF-related disorder (NEDDFL) and is a different gene and
  a different MONDO entity; PMID:33522091 describes that BPTF entity and is
  therefore excluded from every OTUD6B claim in this entry, appearing only as
  evidence on the BPTF differential_diagnoses record. (2) MONDO:0032855
  "neurodevelopmental disorder with dysmorphic facies and distal skeletal
  anomalies" is likewise a separate entity. (3) Other OTU-family
  deubiquitinase disorders are distinct: OTUD5 causes an X-linked
  multiple-congenital-anomaly/neurodevelopmental syndrome, OTUD7A lies in the
  15q13.3 microdeletion interval, and OTUD1/OTUB1 appear in overlapping
  ubiquitin-signalling literature without being the cause of this disorder.
  Every citation used here was checked to name OTUD6B specifically. Most
  OTUD6B PubMed hits are cancer-biology or lncRNA (OTUD6B-AS1) papers that are
  unrelated to the Mendelian disorder and were excluded.

  Frequency discipline. Frequency bands here come from exactly two denominator
  sources, both recorded per phenotype in that phenotype's `notes:`. (1) The
  HPO disease-annotation file (phenotype.hpoa, checked directly against the
  current release) carries per-phenotype `n/m` counts for OMIM:617452 curated
  from the founding cohort PMID:28343629, e.g. Seizure 12/12, Microcephaly
  9/12, Generalized hypotonia 9/12, Feeding difficulties 9/12, Intrauterine
  growth retardation 7/12, Long palpebral fissure 6/12, Broad thumb 6/12,
  Atrial septal defect 3/6. (2) PMID:41188742 supplies an explicit denominator
  for the ocular phenotype. Where neither source applies the band is omitted
  rather than guessed. Important caveat on the HPOA counts: they derive from a
  single, ascertainment-biased 2017 cohort weighted toward severe
  loss-of-function genotypes, so they likely overstate severity across the full
  allelic spectrum. HPOA records Severe intellectual disability as 12/12, which
  is directly contradicted by the later mild cases (PMID:30364145,
  PMID:34354232); this entry therefore models the broader HP:0001249
  Intellectual disability rather than adopting the severe-ID annotation, and
  bands should be read as cohort-specific rather than population estimates.

  HPOA-annotated features not separately modeled here. phenotype.hpoa lists
  additional terms for OMIM:617452 that are not given their own phenotype
  entries: macrotia 7/12, short stature 7/12, decreased body weight 6/12, thin
  upper lip vermilion 6/12, prominent nasal bridge 5/12, scoliosis 5/12,
  retrognathia 4/12, overlapping toe 3/12, autistic behavior 3/12, hypoplasia
  of the corpus callosum 3/12, short neck 3/12, highly arched eyebrow 3/12,
  down-sloping shoulders 3/12, spastic tetraplegia 2/12, chronic constipation
  2/12, sacral dimple 2/12, brachycephaly 1/12, plus unquantified terms
  including inability to walk, ventriculomegaly, failure to thrive, hearing
  impairment, cryptorchidism, and talipes equinovarus. The reason for the
  omission is that these counts derive from the PMID:28343629 full-text table
  rather than from its abstract, and this entry takes its snippets from
  abstracts. That reason must not be overstated: references_cache/PMID_41188742.md
  is cached as full text and does contain a 28-case aggregate table carrying
  several of these rows (short stature 16/28, poor weight gain 14/28, scoliosis
  8/22, cryptorchidism 7/24, abnormal cranial MRI 13/24). Those rows are
  PDF-mangled and bundle several features per line, so they were judged too
  unreliable to quote, but they do exist, and quoting the primary full text is
  the right way to close this gap in a follow-up pass. Long philtrum was
  previously listed here as unsupported by any cached abstract; that was wrong,
  and it is now modeled as its own phenotype from the PMID:34680978 abstract.

  Blended phenotypes and attribution discipline. Three reported probands carry
  a second, independent pathogenic locus that contributes to the observed
  picture: RP1L1 causing the retinal degeneration in PMID:34354232, a
  heterozygous PKD1 variant contributing renal cystic disease in PMID:35707595,
  and a ZMIZ1 splice variant in PMID:34680978. These are co-occurring
  conditions, not OTUD6B modifiers. The RP1L1 retinal degeneration and the PKD1
  renal cystic disease are therefore not attributed to OTUD6B at all. The
  PMID:34680978 proband is handled differently, because that paper's authors
  explicitly propose their facial findings as an OTUD6B phenotype expansion: the
  Williams syndrome-like features (periorbital edema, hanging cheek, long and
  smooth philtrum) and the polydactyly are curated, but every one of them
  carries supports PARTIAL and a note naming the heterozygous ZMIZ1
  c.1491 + 2T > C exon-14-skipping variant as an unresolved confounder, with a
  cross-reference to the ZMIZ1 entry in differential_diagnoses.

  Structured-source citations unavailable. ClinGen has a Definitive
  gene-disease validity assertion for OTUD6B and syndromic intellectual
  disability (assertion 3c60103c-7d9b-4dca-aa03-151130c5d6db, SOP10, AR,
  Intellectual Disability and Autism Gene Curation Expert Panel, 2024-08-22),
  and Orphanet codes this disorder as ORPHA:505237. Neither a `CGGV:` nor an
  `ORPHA:` record could be generated into references_cache in this working
  environment, and the relevant data MANIFEST pins are stale and
  un-refreshable pending #7622, so no structured-source snippet is cited. The
  gene-disease relationship is instead supported here by primary literature.

  Not cited for snippets. PMID:31147255 (first Spanish case) and PMID:32181568
  (Alkuraya, phenotypic-expansion comment) are genuine OTUD6B disorder reports
  but have no abstract text in PubMed, so no verbatim snippet could be taken
  from them; they are recorded in the top-level references block only.
disease_term:
  preferred_term: OTUD6B-related neurodevelopmental disorder
  term:
    id: MONDO:0044319
    label: intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies
parents:
- Neurodevelopmental Disorder
- Autosomal Recessive Syndromic Intellectual Disability
synonyms:
- intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies
- IDDFSDA
- OTUD6B-related syndrome
- OTUD6B-associated intellectual disability
classifications:
  harrisons_chapter:
  - classification_value: NEUROLOGIC
    notes: >-
      The dominant clinical burden is neurodevelopmental: global developmental
      delay, intellectual disability, seizures, hypotonia, and structural brain
      abnormalities.
    evidence:
    - reference: PMID:28343629
      reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6
        independent families with an intellectual disability syndrome associated
        with seizures and dysmorphic features
      explanation: >-
        The defining cohort establishes intellectual disability and seizures as the
        core presenting features, supporting a neurologic chapter assignment.
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
    notes: >-
      A monogenic, autosomal recessive Mendelian disorder diagnosed by exome or
      genome sequencing.
    evidence:
    - reference: PMID:35430327
      reference_title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Intellectual developmental disorder with dysmorphic facies, seizures, and
        distal limb anomalies (IDDFSDA) is an autosomal recessive multisystem
        disorder caused by compound heterozygous or homozygous variants in the gene
        OTUD6B
      explanation: >-
        States the Mendelian, autosomal recessive, single-gene basis of the disorder.
inheritance:
- name: Autosomal recessive inheritance
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    Disease requires biallelic (homozygous or compound heterozygous) OTUD6B
    variants. Reported families include consanguineous pedigrees with homozygous
    alleles and non-consanguineous pedigrees with compound heterozygous alleles.
    Heterozygous carrier parents are unaffected. Recurrence risk for siblings of an
    affected proband is 25 percent, and carrier testing plus genetic counseling are
    indicated for at-risk relatives.
  evidence:
  - reference: PMID:35430327
    reference_title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      an autosomal recessive multisystem disorder caused by compound heterozygous
      or homozygous variants in the gene OTUD6B
    explanation: >-
      Directly states the autosomal recessive, biallelic requirement, including both
      the homozygous and compound heterozygous configurations.
  - reference: PMID:30364145
    reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The segregation in the family was confirmed by Sanger sequencing: the father
      (I1) was carrier of the c.324+1G>C mutation whereas the mother (I2) was
      heterozygous for c.405+1G>A.
    explanation: >-
      Documents biparental transmission of two different alleles to an affected
      compound heterozygous child, with unaffected heterozygous carrier parents.
prevalence:
- population: Worldwide reported literature
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    Fewer than 30 individuals had been reported worldwide as of the 2025 Chinese
    case report; that paper's own literature table enumerates 27 previously
    reported cases plus its index case. No population-based prevalence study
    exists. Orphanet assigns ORPHA:505237 a point-prevalence band of below 1 in
    1,000,000, which would correspond to the BELOW_1_IN_1000000 class and a rate
    of under 0.1 per 100,000; that band is recorded here as context only and is
    not adopted as the structured value, because no ORPHA cache record could be
    generated in this environment to carry a validated snippet (see the
    entry-level notes and #7622). The measure actually asserted is therefore the
    snippet-verifiable published case count.
  evidence:
  - reference: PMID:41188742
    reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      There have been < 30 reported cases globally without fundus and retinal
      lesions.
    explanation: >-
      Provides the published worldwide case count supporting an ultra-rare
      classification based on cases in the literature rather than a population rate.
pathophysiology:
- name: Biallelic OTUD6B Loss-of-Function Variants
  biological_scale: MOLECULAR
  description: >-
    The disorder is initiated by inheritance of two damaging OTUD6B alleles. The
    reported allelic spectrum includes nonsense alleles, canonical splice-donor
    alleles that abolish normal splicing and trigger nonsense-mediated decay,
    frameshift alleles, and rare missense alleles within the catalytic OTU domain.
  genes:
  - preferred_term: OTUD6B
    term:
      id: hgnc:24281
      label: OTUD6B
  downstream:
  - target: Loss of OTUD6B Deubiquitinase Activity
    description: >-
      Damaging biallelic alleles remove or inactivate the OTU-domain
      deubiquitinating enzyme encoded by OTUD6B.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:28343629
      reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Our findings suggest a role for OTUD6B in proteasome function, establish
        that defective OTUD6B function underlies a multisystemic human disorder
      explanation: >-
        The authors frame the disease as arising from defective OTUD6B function,
        the direct consequence of the biallelic damaging alleles.
  - target: Allele-Dependent Residual OTUD6B Function
    description: >-
      Because different alleles leave different amounts of functional protein or
      differently destabilize the fold, the specific genotype sets the residual
      activity available to the developing organism.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:35430327
      reference_title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      snippet: >-
        Our findings suggest that compound LOF and ultrarare missense variants may
        be contribute to the underlying variability expressivity associated with
        this disorder.
      explanation: >-
        Links the specific allele combination to the residual-function and
        expressivity axis. The awkward phrasing is quoted verbatim from the
        published abstract.
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6
      independent families with an intellectual disability syndrome associated
      with seizures and dysmorphic features
    explanation: >-
      Establishes biallelic OTUD6B variants as the initiating genetic lesion in the
      original multi-family discovery cohort.
  - reference: PMID:30364145
    reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Data analysis highlighted the presence of two heterozygous variants affecting
      exons 2 (c.324+1G>C) and 3 (c.405+1G>A) donor splice sites of the OTUD6B gene
    explanation: >-
      An independent replication family in which two canonical splice-donor alleles
      constitute the biallelic lesion.
- name: Loss of OTUD6B Deubiquitinase Activity
  biological_scale: MOLECULAR
  description: >-
    OTUD6B encodes a member of the ovarian tumor (OTU) domain subfamily of
    deubiquitinating enzymes, which remove ubiquitin from substrate proteins and
    thereby counterbalance E1/E2/E3 ubiquitin conjugation. Loss of this activity
    removes a node of control over ubiquitin-dependent protein turnover, trafficking,
    and signaling.
  molecular_functions:
  - preferred_term: cysteine-type deubiquitinase activity
    term:
      id: GO:0004843
      label: cysteine-type deubiquitinase activity
    modifier: DECREASED
  biological_processes:
  - preferred_term: protein deubiquitination
    term:
      id: GO:0016579
      label: protein deubiquitination
    modifier: DECREASED
  downstream:
  - target: Impaired 26S Proteasome Assembly
    description: >-
      Loss of OTUD6B activity is associated with defective incorporation of the 19S
      regulatory particle into the mature 26S proteasome in patient cells.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:28343629
      reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Analysis of peripheral blood mononuclear cells from an affected subject
        showed reduced incorporation of 19S subunits into 26S proteasomes
      explanation: >-
        Cells lacking functional OTUD6B show the 19S incorporation defect,
        establishing the edge from lost deubiquitinase activity to impaired
        proteasome assembly. The intermediate steps are not resolved.
  - target: Dysregulated mTORC1-Linked Translation Initiation
    description: >-
      OTUD6B also acts on the translation initiation machinery downstream of mTORC1,
      so its loss removes a second, proteasome-independent output.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:27864334
      reference_title: "Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation."
      supports: PARTIAL
      evidence_source: IN_VITRO
      snippet: >-
        OTUD6B associates with the protein synthesis initiation complex and
        modifies components of the 48S preinitiation complex.
      explanation: >-
        Establishes the physical and enzymatic link from OTUD6B to translation
        initiation. PARTIAL because the work is in a cancer cell line rather than
        a developmental model.
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      OTUD6B encodes a member of the ovarian tumor domain (OTU)-containing subfamily
      of deubiquitinating enzymes.
    explanation: >-
      Identifies the molecular function lost when OTUD6B is disrupted.
  - reference: PMID:33421002
    reference_title: "Studying OTUD6B-OTUB1 Protein-Protein Interaction by Low-Throughput GFP-Trap Assays and High-Throughput AlphaScreen Assays."
    supports: PARTIAL
    evidence_source: IN_VITRO
    snippet: >-
      we study the protein-protein interaction between the two deubiquitinating
      enzymes OTUB1 and OTUD6B and report for the first time that both proteins
      directly interact with each other
    explanation: >-
      Places OTUD6B within the deubiquitinase interaction network. This is
      supporting context for the enzyme's role in ubiquitin signaling, not direct
      evidence about the disease, hence PARTIAL.
- name: Allele-Dependent Residual OTUD6B Function
  biological_scale: MOLECULAR
  description: >-
    The severity of the clinical phenotype tracks the predicted functional severity
    of the specific OTUD6B alleles. Truncating and splice alleles that trigger
    nonsense-mediated decay give little or no product, whereas some missense alleles
    only locally destabilize the protein and others distort the overall fold. Molecular
    dynamics modeling of two OTU-domain missense alleles predicted localized
    destabilization for the allele found in a mildly affected individual and gross
    fold distortion for the allele found in a severely affected individual. In one
    replication family, residual wild-type splicing of under one percent, together
    with alleles that spare the short OTUD6B-2 isoform, was proposed to explain an
    unusually mild presentation.
  downstream:
  - target: Disrupted Embryonic Organogenesis and Growth
    description: >-
      The amount and quality of residual OTUD6B protein modulates how severely
      development is perturbed, producing the observed severity gradient from severe
      multisystem disease to mild intellectual disability.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:35430327
      reference_title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      snippet: >-
        our findings support that the clinical severity could be related with the
        predicted functional severity of the variations in OTUD6B
      explanation: >-
        Ties residual protein function directly to the severity of the resulting
        developmental phenotype.
  evidence:
  - reference: PMID:35430327
    reference_title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: >-
      it is anticipated that Tyr216Cys in the earlier reported case with less severe
      IDDFSDA will lead to localized destabilization, whereas Ile274Arg in the
      presented index case with the severe IDDFSDA phenotype will lead to significant
      distortion in the overall fold of OTUD6B
    explanation: >-
      Structural modeling and molecular dynamics link predicted protein-level damage
      to observed clinical severity for two OTU-domain missense alleles.
  - reference: PMID:35430327
    reference_title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: >-
      our findings support that the clinical severity could be related with the
      predicted functional severity of the variations in OTUD6B
    explanation: >-
      States the genotype-severity relationship explicitly as the study's conclusion.
  - reference: PMID:30364145
    reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      we performed quantitative analysis by competitive-fluorescent RT-PCR showing
      that the proband presents less than 1% of the wild-type transcript
    explanation: >-
      Direct patient-RNA quantification of residual normal transcript, the measurable
      substrate of the residual-function idea.
- name: Impaired 26S Proteasome Assembly
  biological_scale: CELLULAR
  description: >-
    Peripheral blood mononuclear cells from an affected individual show reduced
    incorporation of 19S regulatory-particle subunits into 26S proteasomes. The
    mature 26S holoenzyme is formed by capping the 20S catalytic core with the 19S
    regulatory particle, so defective 19S incorporation reduces the pool of
    assembly-competent, ubiquitin-receptive proteasomes.
  cell_types:
  - preferred_term: peripheral blood mononuclear cell
    term:
      id: CL:2000001
      label: peripheral blood mononuclear cell
  cellular_components:
  - preferred_term: proteasome accessory complex (19S regulatory particle)
    term:
      id: GO:0022624
      label: proteasome accessory complex
  biological_processes:
  - preferred_term: proteasome assembly
    term:
      id: GO:0043248
      label: proteasome assembly
    modifier: DECREASED
  downstream:
  - target: Reduced Proteasomal Chymotrypsin-Like Activity
    description: >-
      Fewer correctly assembled 26S proteasomes yield lower measured peptidase
      activity in the same patient cells.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:28343629
      reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        showed reduced incorporation of 19S subunits into 26S proteasomes,
        decreased chymotrypsin-like activity
      explanation: >-
        The same patient-cell experiment reports the assembly defect and the
        peptidase-activity deficit together, supporting the direct edge between
        them.
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Analysis of peripheral blood mononuclear cells from an affected subject showed
      reduced incorporation of 19S subunits into 26S proteasomes
    explanation: >-
      Direct patient-cell measurement of the proteasome-assembly defect.
- name: Reduced Proteasomal Chymotrypsin-Like Activity
  biological_scale: MOLECULAR
  description: >-
    Chymotrypsin-like peptidase activity, the rate-limiting catalytic activity of the
    20S core, is decreased in patient peripheral blood mononuclear cells, indicating
    functionally reduced proteolytic throughput and not merely an assembly
    stoichiometry change.
  cellular_components:
  - preferred_term: proteasome complex
    term:
      id: GO:0000502
      label: proteasome complex
  biological_processes:
  - preferred_term: proteasome-mediated ubiquitin-dependent protein catabolic process
    term:
      id: GO:0043161
      label: proteasome-mediated ubiquitin-dependent protein catabolic process
    modifier: DECREASED
  downstream:
  - target: Accumulation of Ubiquitin-Protein Conjugates
    description: >-
      Reduced proteolytic throughput leaves polyubiquitinated substrates undegraded.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:28343629
      reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        decreased chymotrypsin-like activity, and accumulation of
        ubiquitin-protein conjugates
      explanation: >-
        The reduced peptidase activity and the conjugate build-up are reported in
        the same patient cells, supporting the direct degradation-failure edge.
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      decreased chymotrypsin-like activity
    explanation: >-
      Reports the specific reduction of proteasome chymotrypsin-like peptidase
      activity in cells from an affected individual.
- name: Accumulation of Ubiquitin-Protein Conjugates
  biological_scale: CELLULAR
  description: >-
    Polyubiquitinated proteins accumulate in patient cells, the expected consequence
    of a reduced-capacity ubiquitin-proteasome system. This is the proteostatic
    lesion that the developing organism must tolerate.
  biological_processes:
  - preferred_term: ubiquitin-dependent protein catabolic process
    term:
      id: GO:0006511
      label: ubiquitin-dependent protein catabolic process
    modifier: DECREASED
  downstream:
  - target: Impaired Cell Growth and Proliferation
    description: >-
      Failure to clear ubiquitinated regulatory proteins on schedule impairs the
      proliferative programs of developing tissues.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:27864334
      reference_title: "Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation."
      supports: PARTIAL
      evidence_source: IN_VITRO
      snippet: >-
        Deubiquitinases (DUB) are increasingly linked to the regulation of
        fundamental processes in normal and cancer cells, including DNA
        replication and repair, programmed cell death, and oncogenes and tumor
        suppressor signaling.
      explanation: >-
        Supports the general principle that failure of deubiquitinase-dependent
        turnover perturbs replication and proliferation programs. PARTIAL because
        it is a framing statement rather than a direct measurement of this edge in
        OTUD6B-deficient developing tissue.
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      accumulation of ubiquitin-protein conjugates
    explanation: >-
      Patient-cell demonstration that undegraded ubiquitin conjugates build up when
      OTUD6B is lost.
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our findings suggest a role for OTUD6B in proteasome function, establish that
      defective OTUD6B function underlies a multisystemic human disorder
    explanation: >-
      The authors' own synthesis tying the proteasome defect to the multisystem
      human phenotype.
- name: Dysregulated mTORC1-Linked Translation Initiation
  biological_scale: CELLULAR
  description: >-
    Independently of the proteasome arm, OTUD6B regulates protein synthesis
    downstream of mTORC1. It associates with the protein synthesis initiation complex
    and modifies components of the 48S preinitiation complex, and its two main
    splicing isoforms act in opposing directions, with the long OTUD6B-1 isoform
    inhibitory and the short OTUD6B-2 isoform stimulatory. This work was performed in
    non-small cell lung cancer cell lines rather than in neural tissue, so its
    relevance to the human developmental phenotype is inferential.
  biological_processes:
  - preferred_term: regulation of translation
    term:
      id: GO:0006417
      label: regulation of translation
    modifier: ABNORMAL
  downstream:
  - target: Impaired Cell Growth and Proliferation
    description: >-
      Loss of OTUD6B-dependent control over translation initiation contributes to the
      growth and proliferation defect.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:27864334
      reference_title: "Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation."
      supports: PARTIAL
      evidence_source: IN_VITRO
      snippet: >-
        These properties affect NSCLC cell proliferation, because OTUD6B-1
        represses DNA synthesis while OTUD6B-2 promotes it.
      explanation: >-
        Explicitly connects the translation-regulatory properties of OTUD6B to
        proliferation. PARTIAL because it is measured in a cancer cell line.
  evidence:
  - reference: PMID:27864334
    reference_title: "Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation."
    supports: PARTIAL
    evidence_source: IN_VITRO
    snippet: >-
      evidence is presented that the deubiquitinase OTUD6B regulates protein
      synthesis in non-small cell lung cancer (NSCLC) cells, operating downstream
      from mTORC1
    explanation: >-
      Establishes the translation-regulatory function of OTUD6B. Marked PARTIAL
      because the experiments are in a cancer cell line, not in a disease-relevant
      developmental model.
  - reference: PMID:27864334
    reference_title: "Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation."
    supports: PARTIAL
    evidence_source: IN_VITRO
    snippet: >-
      OTUD6B associates with the protein synthesis initiation complex and modifies
      components of the 48S preinitiation complex.
    explanation: >-
      Identifies the specific molecular target of OTUD6B in the translation
      initiation machinery.
- name: Impaired Cell Growth and Proliferation
  biological_scale: CELLULAR
  description: >-
    Both the proteostatic arm and the translational arm converge on reduced growth
    and proliferative capacity. In cell models the two OTUD6B isoforms have opposing
    effects on DNA synthesis, so loss of the balanced isoform pair perturbs
    proliferation control rather than simply slowing it.
  notes: >-
    This node previously bound GO:0030182 neuron differentiation with modifier
    ABNORMAL. That binding was removed: none of the node's evidence addresses
    neuronal differentiation, which is instead an unsupported mechanistic claim
    injected at the bridge to the neurodevelopmental output. The two processes
    now bound are the ones the cited NSCLC DNA-synthesis experiments actually
    speak to.
  biological_processes:
  - preferred_term: cell population proliferation
    term:
      id: GO:0008283
      label: cell population proliferation
    modifier: ABNORMAL
  - preferred_term: growth
    term:
      id: GO:0040007
      label: growth
    modifier: DECREASED
  downstream:
  - target: Disrupted Embryonic Organogenesis and Growth
    description: >-
      A cell-autonomous proliferation deficit during embryogenesis translates into
      reduced somatic growth and malformation of the organs with the highest
      developmental proliferative demand.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:28343629
      reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Homozygous Otud6b knockout mice were subviable, smaller in size, and had
        congenital heart defects, consistent with the severity of loss-of-function
        variants in humans.
      explanation: >-
        Complete loss of the gene in a mammalian model produces exactly the
        reduced-growth-plus-organ-malformation output this edge asserts.
  evidence:
  - reference: PMID:27864334
    reference_title: "Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation."
    supports: PARTIAL
    evidence_source: IN_VITRO
    snippet: >-
      These properties affect NSCLC cell proliferation, because OTUD6B-1 represses
      DNA synthesis while OTUD6B-2 promotes it.
    explanation: >-
      Demonstrates that OTUD6B isoform balance controls proliferation. PARTIAL
      because the model system is a cancer cell line.
- name: Disrupted Embryonic Organogenesis and Growth
  biological_scale: ORGANISM
  description: >-
    The organism-level convergence node. Reduced proliferative and biosynthetic
    capacity during embryogenesis produces prenatal-onset growth restriction,
    microcephaly and structural brain malformation, congenital heart defects, and
    the distal limb and craniofacial patterning anomalies that define the syndrome.
    Homozygous Otud6b knockout mice recapitulate the severe end of this spectrum,
    being subviable and small with congenital heart defects.
  biological_processes:
  - preferred_term: heart development
    term:
      id: GO:0007507
      label: heart development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Homozygous Otud6b knockout mice were subviable, smaller in size, and had
      congenital heart defects, consistent with the severity of loss-of-function
      variants in humans.
    explanation: >-
      An orthologous null mouse reproduces the growth restriction and congenital
      heart disease seen at the severe end of the human spectrum, supporting a
      developmental-organogenesis mechanism.
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      growth retardation with prenatal onset, feeding difficulties, structural brain
      abnormalities, congenital malformations including congenital heart disease,
      and musculoskeletal features
    explanation: >-
      The human multisystem malformation and growth phenotype that this node
      represents.
phenotypes:
- name: Global Developmental Delay
  description: >-
    Delayed acquisition of motor, language, and adaptive milestones is present in
    affected individuals and is typically the presenting concern.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In subjects with predicted loss-of-function alleles, additional features
      include global developmental delay, microcephaly, absent speech, hypotonia
    explanation: >-
      Lists global developmental delay among the features of individuals with
      loss-of-function alleles.
- name: Intellectual Disability
  description: >-
    Intellectual disability is a defining feature. Severity spans the spectrum: the
    most severely affected individuals lack speech and independent ambulation,
    whereas individuals with alleles retaining some function can have mild
    intellectual disability with normal speech and motor development.
  frequency: VERY_FREQUENT
  notes: >-
    Frequency derivation: phenotype.hpoa annotates HP:0010864 Severe
    intellectual disability for OMIM:617452 at 12/12 (100 percent), curated from
    PMID:28343629, supporting a VERY_FREQUENT band (80-100 percent) for
    intellectual disability as such. This entry deliberately binds the broader
    HP:0001249 rather than the severe-ID term, because the 12/12 severity
    annotation reflects the ascertainment-biased 2017 cohort and is contradicted
    by later mild cases (PMID:30364145, PMID:34354232).
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      an intellectual disability syndrome associated with seizures and dysmorphic
      features
    explanation: >-
      Intellectual disability is the anchoring feature named in the original
      gene-disease report.
  - reference: PMID:30364145
    reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      At the latest neurological evaluation, at 6 years of age, she has mild
      intellectual disability, mild motor difficulty, and episodic behavioral
      disorders.
    explanation: >-
      Documents the mild end of the intellectual disability spectrum in a
      replication case.
- name: Seizures
  description: >-
    Seizures are part of the core triad and are named in the disorder's canonical
    label. Reported semiologies include generalized tonic-clonic seizures, and onset
    may be in infancy or later in childhood.
  frequency: VERY_FREQUENT
  notes: >-
    Frequency derivation: phenotype.hpoa annotates HP:0001250 Seizure for
    OMIM:617452 at 12/12 (100 percent), curated from PMID:28343629. That maps to
    the VERY_FREQUENT band (80-100 percent).
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      an intellectual disability syndrome associated with seizures and dysmorphic
      features
    explanation: >-
      Seizures are named as a core feature of the syndrome in the discovery cohort.
  - reference: PMID:30364145
    reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      At 5 years, tonic-clonic seizures occurred, thus valproate treatment was
      started.
    explanation: >-
      Documents generalized tonic-clonic semiology and childhood onset in an
      individual with biallelic OTUD6B splice variants.
- name: Dysmorphic Facial Features
  description: >-
    A recognizable dysmorphic facial gestalt accompanies the neurodevelopmental
    phenotype. Reported components include long palpebral fissures and prominent,
    cupped ears; the resemblance to Kabuki syndrome has led to initial misdiagnosis.
  phenotype_term:
    preferred_term: Abnormal facial shape
    term:
      id: HP:0001999
      label: Abnormal facial shape
  evidence:
  - reference: PMID:38389298
    reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Physical differences described for affected individuals suggest that the
      disorder may be clinically recognizable, but previous publications have
      reported an initial clinical suspicion for Kabuki syndrome (KS) in some
      affected individuals.
    explanation: >-
      Establishes a recognizable dysmorphic facial phenotype and documents the
      clinically important Kabuki syndrome overlap.
- name: Long Palpebral Fissures
  description: >-
    Horizontally elongated palpebral fissures contribute to the Kabuki-like facial
    impression in affected individuals.
  frequency: FREQUENT
  notes: >-
    Frequency derivation: phenotype.hpoa annotates HP:0000637 Long palpebral
    fissure for OMIM:617452 at 6/12 (50 percent), curated from PMID:28343629.
    That maps to the FREQUENT band (30-79 percent).
  phenotype_term:
    preferred_term: Long palpebral fissure
    term:
      id: HP:0000637
      label: Long palpebral fissure
  evidence:
  - reference: PMID:38389298
    reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      clinical manifestations such as long palpebral fissures, prominent and cupped
      ears, developmental delay, growth deficiency, persistent fetal fingertip pads,
      vertebral anomaly, and seizures in the proband
    explanation: >-
      Names long palpebral fissures in three siblings with biallelic OTUD6B variants.
- name: Cupped Ears
  description: >-
    Prominent, cupped auricles are part of the reported craniofacial phenotype.
  phenotype_term:
    preferred_term: Cupped ear
    term:
      id: HP:0000378
      label: Cupped ear
  evidence:
  - reference: PMID:38389298
    reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      long palpebral fissures, prominent and cupped ears
    explanation: >-
      Directly reports prominent and cupped ears in affected siblings.
- name: Periorbital Edema
  description: >-
    Puffiness of the periorbital region was one of three facial features that led
    the reporting authors to describe the gestalt as Williams syndrome-like and to
    propose it as an expansion of the OTUD6B facial phenotype.
  notes: >-
    Attribution caveat. This observation comes from the single proband of
    PMID:34680978, who carries both a hemizygous OTUD6B c.873delA allele in trans
    with a paternally inherited 0.118 Mb 8q21.3 whole-gene deletion AND a
    heterozygous ZMIZ1 splice variant, c.1491 + 2T > C, shown by mRNA study to
    skip exon 14. ZMIZ1 causes its own autosomal dominant neurodevelopmental
    disorder with dysmorphic facies (MONDO:0032855), which is recorded in this
    entry's differential_diagnoses, so the facial gestalt in this proband cannot
    be attributed to OTUD6B alone. The authors themselves only "suggest" the
    expansion. Curated with supports PARTIAL for that reason. No frequency band
    is given: this is a single case with no denominator.
  phenotype_term:
    preferred_term: Periorbital edema
    term:
      id: HP:0100539
      label: Periorbital edema
  evidence:
  - reference: PMID:34680978
    reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We suggest that Williams syndrome-like phenotypes, namely, periorbital
      edema, hanging cheek, and long and smooth philtrum represent expanded
      phenotypes of OTUD6B-related ID.
    explanation: >-
      Author-asserted phenotypic expansion naming periorbital edema. PARTIAL
      because the proband also carries a ZMIZ1 exon-14-skipping splice variant
      and the authors frame the attribution as a suggestion rather than an
      established finding.
- name: Hanging Cheek
  description: >-
    A drooping, hanging appearance of the cheeks was the second of the three
    Williams syndrome-like facial features proposed as an OTUD6B phenotype
    expansion.
  notes: >-
    Ontology gap. HPO has no term for "hanging cheek". HP:0034273 Premature
    sagging cheeks is defined as sagging beyond that expected for age and
    HP:0000293 Full cheeks describes increased fullness, neither of which is what
    the authors describe, so this is bound to the immediate parent HP:0004426
    Abnormal cheek morphology with the published wording kept in preferred_term.
    Same attribution caveat as Periorbital Edema: the single PMID:34680978
    proband also carries a heterozygous ZMIZ1 c.1491 + 2T > C splice variant that
    skips exon 14, and ZMIZ1-related disorder (MONDO:0032855, in this entry's
    differential_diagnoses) itself causes dysmorphic facies, so attribution to
    OTUD6B alone is not secure.
  phenotype_term:
    preferred_term: Hanging cheek
    term:
      id: HP:0004426
      label: Abnormal cheek morphology
  evidence:
  - reference: PMID:34680978
    reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We suggest that Williams syndrome-like phenotypes, namely, periorbital
      edema, hanging cheek, and long and smooth philtrum represent expanded
      phenotypes of OTUD6B-related ID.
    explanation: >-
      Author-asserted phenotypic expansion naming hanging cheek. PARTIAL because
      of the co-occurring ZMIZ1 splice variant in the same proband and the
      authors' own hedged framing.
- name: Long Philtrum
  description: >-
    An increased distance between the nasal base and the upper lip vermilion
    border was the third Williams syndrome-like facial feature proposed as an
    OTUD6B phenotype expansion. It is independently annotated in phenotype.hpoa
    for OMIM:617452 at 7/12 from the founding cohort, which corroborates the
    feature even though this entry's snippet comes from PMID:34680978.
  notes: >-
    No frequency band is asserted. phenotype.hpoa does carry long philtrum at
    7/12 for OMIM:617452 from PMID:28343629, which would map to FREQUENT, but the
    snippet cited here is the single-proband PMID:34680978 sentence rather than
    the cohort count, so the band is omitted rather than attributed to a source
    this entry does not quote. Same ZMIZ1 attribution caveat as Periorbital Edema
    applies to the PMID:34680978 observation itself.
  phenotype_term:
    preferred_term: Long philtrum
    term:
      id: HP:0000343
      label: Long philtrum
  evidence:
  - reference: PMID:34680978
    reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We suggest that Williams syndrome-like phenotypes, namely, periorbital
      edema, hanging cheek, and long and smooth philtrum represent expanded
      phenotypes of OTUD6B-related ID.
    explanation: >-
      Author-asserted phenotypic expansion naming a long philtrum. PARTIAL
      because the proband also carries a ZMIZ1 splice variant, though the
      independent HPOA annotation of long philtrum at 7/12 for OMIM:617452 makes
      this the best-corroborated member of the Williams-like triad.
- name: Smooth Philtrum
  description: >-
    Flattening of the philtral ridges accompanied the long philtrum in the same
    proband and was reported as part of the Williams syndrome-like gestalt.
  notes: >-
    Curated separately from Long Philtrum because HPO codes philtral length
    (HP:0000343) and philtral depth (HP:0000319) as distinct terms, and the
    source sentence asserts both. Unlike long philtrum, smooth philtrum has no
    corroborating HPOA annotation for OMIM:617452, so it rests entirely on this
    one proband, who also carries the heterozygous ZMIZ1 c.1491 + 2T > C variant.
  phenotype_term:
    preferred_term: Smooth philtrum
    term:
      id: HP:0000319
      label: Smooth philtrum
  evidence:
  - reference: PMID:34680978
    reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We suggest that Williams syndrome-like phenotypes, namely, periorbital
      edema, hanging cheek, and long and smooth philtrum represent expanded
      phenotypes of OTUD6B-related ID.
    explanation: >-
      Author-asserted phenotypic expansion naming a smooth philtrum. PARTIAL
      because it is a single-proband observation confounded by a co-occurring
      ZMIZ1 exon-14-skipping variant.
- name: Microcephaly
  description: >-
    Reduced occipitofrontal head circumference is reported in individuals with
    predicted loss-of-function alleles, consistent with the impaired-proliferation
    mechanism.
  frequency: FREQUENT
  notes: >-
    Frequency derivation: phenotype.hpoa annotates HP:0000252 Microcephaly for
    OMIM:617452 at 9/12 (75 percent), curated from PMID:28343629. That maps to
    the FREQUENT band (30-79 percent).
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In subjects with predicted loss-of-function alleles, additional features
      include global developmental delay, microcephaly, absent speech, hypotonia
    explanation: >-
      Microcephaly is listed among the features of the loss-of-function subgroup.
- name: Absent Speech
  description: >-
    Failure to develop expressive speech occurs at the severe end of the spectrum,
    in individuals with predicted loss-of-function alleles.
  phenotype_term:
    preferred_term: Absent speech
    term:
      id: HP:0001344
      label: Absent speech
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      additional features include global developmental delay, microcephaly, absent
      speech, hypotonia
    explanation: >-
      Absent speech is reported in the loss-of-function subgroup.
- name: Hypotonia
  description: >-
    Diminished muscle tone contributes to feeding difficulty and to delayed gross
    motor milestones.
  frequency: FREQUENT
  notes: >-
    Frequency derivation: phenotype.hpoa annotates HP:0001290 Generalized
    hypotonia for OMIM:617452 at 9/12 (75 percent), curated from PMID:28343629.
    That maps to the FREQUENT band (30-79 percent). The generalized term is used
    here to match the HPO disease annotation.
  phenotype_term:
    preferred_term: Generalized hypotonia
    term:
      id: HP:0001290
      label: Generalized hypotonia
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      global developmental delay, microcephaly, absent speech, hypotonia, growth
      retardation with prenatal onset
    explanation: >-
      Hypotonia is listed among the features of individuals with loss-of-function
      alleles.
- name: Prenatal-Onset Growth Restriction
  description: >-
    Growth failure begins in utero and persists postnatally, giving short stature and
    low weight in addition to microcephaly.
  frequency: FREQUENT
  notes: >-
    Frequency derivation: phenotype.hpoa annotates HP:0001511 Intrauterine
    growth retardation for OMIM:617452 at 7/12 (58 percent), curated from
    PMID:28343629. That maps to the FREQUENT band (30-79 percent).
  phenotype_term:
    preferred_term: Intrauterine growth retardation
    term:
      id: HP:0001511
      label: Intrauterine growth retardation
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      hypotonia, growth retardation with prenatal onset, feeding difficulties
    explanation: >-
      Explicitly reports growth retardation with prenatal onset.
  - reference: PMID:38389298
    reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      developmental delay, growth deficiency, persistent fetal fingertip pads
    explanation: >-
      Independent confirmation of growth deficiency in a second family.
- name: Feeding Difficulties
  description: >-
    Poor feeding is common and, at the severe end of the spectrum, can require
    gastrostomy or other enteral feeding support.
  frequency: FREQUENT
  notes: >-
    Frequency derivation: phenotype.hpoa annotates HP:0011968 Feeding
    difficulties for OMIM:617452 at 9/12 (75 percent), curated from
    PMID:28343629. That maps to the FREQUENT band (30-79 percent).
  phenotype_term:
    preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      growth retardation with prenatal onset, feeding difficulties, structural brain
      abnormalities
    explanation: >-
      Feeding difficulties are reported in the loss-of-function subgroup.
- name: Structural Brain Abnormalities
  description: >-
    Nonspecific structural brain abnormalities are seen on neuroimaging in a subset
    of affected individuals, with inter- and intrafamilial variability in the imaging
    findings.
  phenotype_term:
    preferred_term: Abnormal brain morphology
    term:
      id: HP:0012443
      label: Abnormal brain morphology
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      feeding difficulties, structural brain abnormalities, congenital malformations
      including congenital heart disease
    explanation: >-
      Reports structural brain abnormalities as part of the multisystem phenotype.
  - reference: PMID:34354232
    reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      our patients showed inter- and intrafamilial differences with regard to the
      clinical and brain imaging findings
    explanation: >-
      Documents variability of the brain imaging phenotype within and between
      OTUD6B families.
- name: Congenital Heart Disease
  description: >-
    Congenital cardiac malformations occur in a subset of affected individuals and
    are recapitulated in the Otud6b null mouse, making cardiac evaluation part of
    initial assessment. Septal defects predominate, but conotruncal malformation
    also occurs: one proband was ascertained through antenatal diagnosis of
    Tetralogy of Fallot, and a preceding pregnancy in the same family was
    terminated for the same finding.
  frequency: FREQUENT
  notes: >-
    Frequency derivation: phenotype.hpoa annotates the specific cardiac lesions
    for OMIM:617452 against a cardiac-evaluated denominator of 6, giving atrial
    septal defect 3/6 (50 percent) and ventricular septal defect 2/6 (33
    percent), both curated from PMID:28343629. Either maps to the FREQUENT band
    (30-79 percent), so FREQUENT is applied to the parent cardiac term. Note the
    denominator is 6, not the 12 used for the neurological terms, because only a
    subset of the founding cohort had cardiac assessment reported.
  phenotype_term:
    preferred_term: Abnormal heart morphology
    term:
      id: HP:0001627
      label: Abnormal heart morphology
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      congenital malformations including congenital heart disease, and
      musculoskeletal features
    explanation: >-
      Reports congenital heart disease among the malformations in affected humans.
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Homozygous Otud6b knockout mice were subviable, smaller in size, and had
      congenital heart defects
    explanation: >-
      The orthologous null mouse independently supports a causal role for OTUD6B loss
      in congenital heart defects.
  - reference: PMID:35707595
    reference_title: "A New Family with a Novel OTUD6B Mutation: Practicing Whole Exome Sequencing for Antenatal Diagnosis of Tetralogy of Fallot."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we report one additional case with Tetralogy of Fallot (ToF), who has
      microcephaly and dysmorphic features along with renal parenchymal disease
      with simple cortical cysts
    explanation: >-
      Extends the cardiac phenotype beyond septal defects to a conotruncal
      malformation in a genetically confirmed individual. The renal cystic disease
      in the same proband is attributed by the authors to a separate PKD1 variant
      and is therefore not curated as an OTUD6B feature here.
- name: Persistent Fetal Fingertip Pads
  description: >-
    Persistence of the fetal fingertip pads is one of the recognizable distal limb
    findings and, together with broad distal phalanges and prominent interphalangeal
    joints, has been proposed as a diagnostic handle.
  phenotype_term:
    preferred_term: Prominent fingertip pads
    term:
      id: HP:0001212
      label: Prominent fingertip pads
  evidence:
  - reference: PMID:38389298
    reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      growth deficiency, persistent fetal fingertip pads, vertebral anomaly, and
      seizures in the proband
    explanation: >-
      Directly reports persistent fetal fingertip pads in affected siblings.
  - reference: PMID:34354232
    reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Broad distal phalanges (especially the thumbs and halluces) with prominent
      interphalangeal joints and fetal pads were recognized in all patients and
      hence considered pathognomonic.
    explanation: >-
      Independent report of fetal pads in all five patients of two Egyptian families.
- name: Broad Distal Phalanges
  description: >-
    Broadening of the distal phalanges, most conspicuous in the thumbs and halluces,
    is one of the distal limb anomalies named in the disorder's canonical label. In
    one series this finding was present in all five affected individuals and was
    considered pathognomonic by the authors.
  frequency: FREQUENT
  notes: >-
    Frequency derivation: phenotype.hpoa annotates HP:0011304 Broad thumb for
    OMIM:617452 at 6/12 (50 percent), curated from PMID:28343629. That maps to
    the FREQUENT band (30-79 percent). The HPO disease annotation uses the thumb
    term, which is also the digit the primary reports single out, so that term is
    bound here; the halluces are affected in parallel but are not separately
    annotated in HPOA.
  phenotype_term:
    preferred_term: Broad distal phalanges of the thumbs and halluces
    term:
      id: HP:0011304
      label: Broad thumb
  evidence:
  - reference: PMID:34354232
    reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Broad distal phalanges (especially the thumbs and halluces) with prominent
      interphalangeal joints and fetal pads were recognized in all patients and
      hence considered pathognomonic.
    explanation: >-
      Reports broad distal phalanges of thumbs and halluces in all patients studied.
- name: Prominent Interphalangeal Joints
  description: >-
    Prominence of the interphalangeal joints accompanies the broad distal phalanges
    in the characteristic hand and foot phenotype.
  phenotype_term:
    preferred_term: Prominent interphalangeal joints
    term:
      id: HP:0006237
      label: Prominent interphalangeal joints
  evidence:
  - reference: PMID:34354232
    reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Broad distal phalanges (especially the thumbs and halluces) with prominent
      interphalangeal joints and fetal pads
    explanation: >-
      Directly reports prominent interphalangeal joints as part of the distal limb
      phenotype.
- name: Polydactyly
  description: >-
    Supernumerary digits were reported in one affected girl alongside terminal
    broadening of the fingers, extending the distal limb phenotype beyond
    broadening and joint prominence. This is a single-case observation and is not
    part of the HPO disease annotation for OMIM:617452.
  phenotype_term:
    preferred_term: Polydactyly
    term:
      id: HP:0010442
      label: Polydactyly
  evidence:
  - reference: PMID:34680978
    reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient also had terminal broadening of the fingers and polydactyly.
    explanation: >-
      Reports polydactyly with terminal digital broadening. Marked PARTIAL because
      this proband also carries a heterozygous ZMIZ1 c.1491 + 2T > C splice variant
      that skips exon 14, so attribution of the limb finding to OTUD6B alone is not
      secure. See the ZMIZ1 entry (MONDO:0032855) in differential_diagnoses.
- name: Macrodontia
  description: >-
    Abnormally large teeth are part of a distinctive orodental phenotype that also
    includes dental crowding, abnormally shaped teeth, and thick alveolar ridges.
  phenotype_term:
    preferred_term: Macrodontia
    term:
      id: HP:0001572
      label: Macrodontia
  evidence:
  - reference: PMID:34354232
    reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      various orodental features were present including macrodontia, dental
      crowding, abnormally shaped teeth, and thick alveolar ridges
    explanation: >-
      Directly reports macrodontia in the Egyptian OTUD6B cohort.
- name: Dental Crowding
  description: >-
    Crowding of the dental arch accompanies macrodontia in the orodental phenotype.
  phenotype_term:
    preferred_term: Dental crowding
    term:
      id: HP:0000678
      label: Dental crowding
  evidence:
  - reference: PMID:34354232
    reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      including macrodontia, dental crowding, abnormally shaped teeth, and thick
      alveolar ridges
    explanation: >-
      Directly reports dental crowding.
- name: Abnormally Shaped Teeth
  description: >-
    Abnormal crown morphology is reported alongside macrodontia and crowding.
  phenotype_term:
    preferred_term: Abnormal dental morphology
    term:
      id: HP:0006482
      label: Abnormal dental morphology
  evidence:
  - reference: PMID:34354232
    reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      macrodontia, dental crowding, abnormally shaped teeth, and thick alveolar
      ridges
    explanation: >-
      Directly reports abnormally shaped teeth.
- name: Delayed Eruption of Primary Teeth
  description: >-
    Delayed eruption of the primary dentition was reported as a novel feature in a
    three-sibling family, extending the orodental phenotype.
  phenotype_term:
    preferred_term: Delayed eruption of primary teeth
    term:
      id: HP:0000680
      label: Delayed eruption of primary teeth
  evidence:
  - reference: PMID:38389298
    reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      previously unreported clinical manifestations such as delayed eruption of
      primary dentition, soft doughy skin with reduced sweating, and mirror movements
      present in our patients suggest an expansion of the phenotype
    explanation: >-
      Reports delayed eruption of primary dentition as a phenotype-expanding finding.
- name: Vertebral Anomalies
  description: >-
    Vertebral segmentation or morphology anomalies are reported among the
    musculoskeletal features.
  phenotype_term:
    preferred_term: Abnormal vertebral morphology
    term:
      id: HP:0003468
      label: Abnormal vertebral morphology
  evidence:
  - reference: PMID:38389298
    reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      persistent fetal fingertip pads, vertebral anomaly, and seizures in the proband
    explanation: >-
      Reports a vertebral anomaly in the proband of the three-sibling family.
- name: Mirror Movements
  description: >-
    Involuntary mirrored movements of the contralateral hand were reported as a novel
    neurological finding, suggesting abnormal development or decussation of
    corticospinal projections.
  phenotype_term:
    preferred_term: Mirror movements
    term:
      id: HP:0001335
      label: Bimanual synkinesia
  evidence:
  - reference: PMID:38389298
    reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      delayed eruption of primary dentition, soft doughy skin with reduced sweating,
      and mirror movements present in our patients suggest an expansion of the
      phenotype
    explanation: >-
      Reports mirror movements as a newly described feature in OTUD6B-related disease.
- name: Soft Doughy Skin
  description: >-
    Soft, doughy skin texture was described as part of the phenotype expansion in a
    three-sibling family.
  phenotype_term:
    preferred_term: Soft skin
    term:
      id: HP:0000977
      label: Soft skin
  evidence:
  - reference: PMID:38389298
    reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      soft doughy skin with reduced sweating
    explanation: >-
      Directly reports soft doughy skin.
- name: Reduced Sweating
  description: >-
    Reduced sweating was reported together with the soft doughy skin texture,
    suggesting an ectodermal component to the phenotype.
  phenotype_term:
    preferred_term: Hypohidrosis
    term:
      id: HP:0000966
      label: Hypohidrosis
  evidence:
  - reference: PMID:38389298
    reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      soft doughy skin with reduced sweating, and mirror movements
    explanation: >-
      Directly reports reduced sweating.
- name: Hypothyroidism
  description: >-
    Hypothyroidism has been reported in multiple unrelated affected individuals and
    is a treatable comorbidity, making thyroid function testing worthwhile at
    diagnosis.
  phenotype_term:
    preferred_term: Hypothyroidism
    term:
      id: HP:0000821
      label: Hypothyroidism
  evidence:
  - reference: PMID:32924626
    reference_title: "Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      this is the third patient with associated hypothyroidism and
      hypogammaglobulinemia, underscoring the value of screening for these
      conditions in other patients
    explanation: >-
      Identifies hypothyroidism recurring across at least three unrelated affected
      individuals.
  - reference: PMID:41188742
    reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A 6-month-old girl presented with nystagmus and hypothyroidism.
    explanation: >-
      A further independent case of hypothyroidism in a genetically confirmed
      individual.
- name: Hypogammaglobulinemia
  description: >-
    Reduced circulating immunoglobulin has been reported alongside hypothyroidism in
    a minority of affected individuals, prompting recommendations for immunologic
    screening.
  phenotype_term:
    preferred_term: Hypogammaglobulinemia
    term:
      id: HP:0004313
      label: Decreased circulating immunoglobulin concentration
  evidence:
  - reference: PMID:32924626
    reference_title: "Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the third patient with associated hypothyroidism and hypogammaglobulinemia
    explanation: >-
      Reports hypogammaglobulinemia recurring in a third unrelated affected
      individual.
- name: Nystagmus
  description: >-
    Nystagmus was the presenting sign in a 6-month-old girl who also had optic disc
    hypoplasia and retinal abnormalities.
  phenotype_term:
    preferred_term: Nystagmus
    term:
      id: HP:0000639
      label: Nystagmus
  evidence:
  - reference: PMID:41188742
    reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A 6-month-old girl presented with nystagmus and hypothyroidism.
    explanation: >-
      Reports nystagmus as the presenting ocular sign in a genetically confirmed case.
- name: Optic Disc Hypoplasia and Ocular Developmental Anomalies
  description: >-
    Optic disc hypoplasia with retinal abnormalities was described in a single
    reported individual. The authors emphasize that this was the first such report
    and call for further investigation before accepting ocular developmental anomaly
    as an established part of the phenotype.
  frequency: VERY_RARE
  notes: >-
    Frequency derivation: PMID:41188742 states that none of the 27 previously
    reported IDDFSDA cases exhibited ocular developmental abnormalities, and reports
    one new case with them. That gives 1 of 28 reported individuals (approximately
    3.6 percent), which maps to the VERY_RARE band (1-4 percent). This is the only
    phenotype in this entry with a published denominator; all others omit a
    frequency band deliberately.
  phenotype_term:
    preferred_term: Optic disc hypoplasia
    term:
      id: HP:0007766
      label: Optic disc hypoplasia
  evidence:
  - reference: PMID:41188742
    reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      On admission, optic disc hypoplasia and retinal abnormalities were detected
      with a typical phenotype of IDDFSDA.
    explanation: >-
      Reports optic disc hypoplasia and retinal abnormalities in a genetically
      confirmed individual.
  - reference: PMID:41188742
    reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Significantly, none of the 27 previously reported IDDFSDA cases exhibited
      ocular developmental abnormalities.
    explanation: >-
      Supplies the denominator for the VERY_RARE band and simultaneously flags that
      the association rests on a single observation.
- name: Retinal Degeneration
  description: >-
    Retinal degeneration was initially observed in two brothers with homozygous
    OTUD6B variants, but exome reanalysis showed it was caused by a co-segregating
    homozygous RP1L1 nonsense variant causing autosomal recessive retinitis
    pigmentosa 88, not by OTUD6B. This entry records retinal degeneration as
    explicitly excluded from the OTUD6B phenotype. It is distinct from the optic
    disc hypoplasia and retinal abnormalities reported separately in PMID:41188742,
    which remain a single unreplicated observation.
  phenotype_term:
    preferred_term: Retinal degeneration
    term:
      id: HP:0000546
      label: Retinal degeneration
  evidence:
  - reference: PMID:34354232
    reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Retinal degeneration, albeit present in both patients from Family I, was shown
      to be unrelated to OTUD6B, demonstrating the need for in-depth analysis of WES
      data in consanguineous families to uncover simultaneous autosomal recessive
      disorders.
    explanation: >-
      Explicitly refutes retinal degeneration as part of the OTUD6B phenotype and
      attributes it to a second, independent recessive disorder in the same family.
  - reference: PMID:34354232
    reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biallelic pathogenic variants in RP1L1 cause autosomal recessive retinitis
      pigmentosa type 88 (RP88). Thus, RP1L1 dysfunction likely accounts for the
      visual phenotype in this family
    explanation: >-
      Names the alternative causal gene, closing the loop on the exclusion.
genetic:
- name: OTUD6B biallelic pathogenic variants
  gene_term:
    preferred_term: OTUD6B
    term:
      id: hgnc:24281
      label: OTUD6B
  association: Biallelic pathogenic variants are causative for IDDFSDA
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  inheritance:
  - name: Autosomal recessive inheritance
    inheritance_term:
      preferred_term: Autosomal recessive inheritance
      term:
        id: HP:0000007
        label: Autosomal recessive inheritance
    evidence:
    - reference: PMID:35430327
      reference_title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        an autosomal recessive multisystem disorder caused by compound heterozygous
        or homozygous variants in the gene OTUD6B
      explanation: >-
        States the recessive, biallelic disease model for OTUD6B.
  notes: >-
    Reported disease alleles span several classes. Nonsense: c.271C>T p.(Gln91Ter)
    (Egyptian family) and c.433C>T p.(Arg145*) (Mexican case). Canonical splice
    donor: c.324+1G>C and c.405+1G>A (Italian replication case), functionally shown
    to cause exon 2 and exon 3 skipping with nonsense-mediated decay. Missense in the
    OTU domain: c.767G>T p.(Gly256Val), c.815T>G p.(Ile272Arg), plus Tyr216Cys and
    Ile274Arg analyzed by molecular dynamics. Compound heterozygous
    frameshift-plus-missense genotypes have also been reported, and in one proband
    the second hit was a 0.118 Mb paternally inherited 8q21.3 deletion spanning
    OTUD6B in trans with a maternal frameshift, so chromosomal microarray as well as
    sequencing can be needed to establish biallelic status. Reported missense alleles
    cluster in or immediately adjacent to the OTU catalytic domain. Transcript
    numbering follows NM_016023.5 and the 293-residue UniProt Q8N6M0 protein; note
    that the original 2017 paper's full text uses a longer isoform numbering, so
    residue positions quoted across papers are not directly comparable without
    checking the isoform. ClinGen classifies the OTUD6B-syndromic intellectual
    disability relationship as Definitive (AR, SOP10, Intellectual Disability and
    Autism Gene Curation Expert Panel, 2024-08-22); that structured assertion could
    not be cached as a CGGV reference here (see the entry-level notes), so it is
    recorded descriptively rather than as a validated snippet.
  evidence:
  - reference: PMID:28343629
    reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6
      independent families with an intellectual disability syndrome associated with
      seizures and dysmorphic features
    explanation: >-
      The gene-disease-establishing multi-family cohort.
  - reference: PMID:34354232
    reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Whole-exome sequencing (WES) identified a novel nonsense variant in OTUD6B
      (c.271C>T, p.(Gln91Ter))
    explanation: >-
      Documents a specific nonsense allele identified by exome sequencing.
  - reference: PMID:34354232
    reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In Family II, targeted sequencing revealed a novel homozygous missense variant
      (c.767G>T, p.(Gly256Val)), confirming the clinically suspected OTUD6B-related ID.
    explanation: >-
      Documents a homozygous OTU-domain missense allele.
  - reference: PMID:32924626
    reference_title: "Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The homozygous c.433C>T (p.Arg145*) variant of the OTUD6B gene confirmed this
      intellectual disability syndrome.
    explanation: >-
      Documents a homozygous nonsense allele in an independent case.
  - reference: PMID:30364145
    reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      both variants affect OTUD6B splicing and lead to the production of aberrant
      transcripts
    explanation: >-
      Patient-RNA functional validation that the two canonical splice-donor alleles
      are indeed loss-of-function.
  - reference: PMID:35707595
    reference_title: "A New Family with a Novel OTUD6B Mutation: Practicing Whole Exome Sequencing for Antenatal Diagnosis of Tetralogy of Fallot."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      was revealed by whole exome sequencing (WES) along with a previously
      reported heterozygous PKD1 variant, unraveling the blended phenotype
      observed in the proband.
    explanation: >-
      Documents a further homozygous OTU-domain missense allele, c.815T>G
      p.(Ile272Arg), and is an explicit
      worked example of a blended two-locus phenotype, which matters for attribution
      discipline in this disorder.
  - reference: PMID:34680978
    reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The CMA showed a paternally inherited 0.118 Mb deletion of 8q21.3,
      chr8:92084087-92202189, with OTUD6B involved.
    explanation: >-
      Documents the allelic class of a whole-gene copy-number deletion supplying
      the second hit in trans with a point mutation. The diagnostic-workup
      consequence of this allelic class is modeled in the diagnosis section
      rather than here.
diagnosis:
- name: Trio Exome Sequencing
  description: >-
    There are no formal clinical diagnostic criteria; the diagnosis is molecular.
    Trio-based exome sequencing is the appropriate first-line test for a child
    with global developmental delay, seizures, the distal limb findings, and a
    dysmorphic facial gestalt, and it is how the reported cases were ascertained.
    The trio design matters specifically because the disorder is autosomal
    recessive: phasing the two candidate alleles across the parents is what
    establishes that they are in trans, and it is also what identifies each
    parent as a carrier for counseling.
  diagnosis_term:
    preferred_term: trio exome sequencing
    term:
      id: NCIT:C101295
      label: Whole Exome Sequencing
  results: >-
    Biallelic OTUD6B variants in trans; reported alleles include splice-donor,
    frameshift, nonsense, and OTU-domain missense changes
  markers: OTUD6B (hgnc:24281)
  evidence:
  - reference: PMID:41188742
    reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Pathogenic gene variants were identified using whole exome trio sequencing
      (trioWES) and confirmed using Sanger sequencing.
    explanation: >-
      States the trio exome plus Sanger confirmation pathway that produced the
      molecular diagnosis in a genetically confirmed case.
  - reference: PMID:30364145
    reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Sanger sequencing confirmed the segregation of the variants in the family,
      showing that both parents are carriers of one mutation.
    explanation: >-
      Documents the parental segregation step that establishes the two alleles
      are in trans, which is the reason the trio design is specified here.
- name: Chromosomal Microarray
  description: >-
    Chromosomal microarray is required alongside sequencing rather than being
    superseded by it. One reported proband is a compound heterozygote for an
    OTUD6B point mutation and a paternally inherited 0.118 Mb whole-gene deletion
    of 8q21.3; exome sequencing alone reports that individual as a single
    heterozygote and the diagnosis is missed. A single apparently heterozygous
    OTUD6B variant in a clinically compatible child should therefore prompt
    copy-number analysis of the locus.
  diagnosis_term:
    preferred_term: chromosomal microarray testing
    term:
      id: NCIT:C18477
      label: Microarray Analysis
  results: >-
    May reveal a whole-gene or partial-gene 8q21.3 deletion supplying the second
    hit in trans with a sequence variant
  markers: 8q21.3
  evidence:
  - reference: PMID:34680978
    reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Cytogenomic microarray (CMA), whole exome sequencing (WES), and mRNA
      analysis were performed.
    explanation: >-
      Records the combined assay panel used to reach this diagnosis, with CMA run
      in parallel with sequencing rather than as a superseded first-tier test.
  - reference: PMID:34680978
    reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The CMA showed a paternally inherited 0.118 Mb deletion of 8q21.3,
      chr8:92084087-92202189, with OTUD6B involved.
    explanation: >-
      The specific copy-number second hit that only microarray detected, which is
      what makes CMA non-optional in this disorder's workup.
- name: Reflex OTUD6B Testing in Suspected Rubinstein-Taybi or Kabuki Syndrome
  description: >-
    The facial gestalt overlaps two better-known syndromes, so affected children
    are commonly worked up for those first. The authors of the first replication
    report explicitly recommend screening OTUD6B in a child suspected of having
    Rubinstein-Taybi syndrome once CREBBP and EP300 are negative. An initial
    clinical suspicion of Kabuki syndrome has likewise been recorded in several
    affected individuals. This is actionable reflex testing rather than an
    academic differential.
  diagnosis_term:
    preferred_term: reflex OTUD6B genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  results: >-
    Biallelic OTUD6B variants in a child previously worked up, negatively, for
    Rubinstein-Taybi or Kabuki syndrome
  evidence:
  - reference: PMID:30364145
    reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      appropriateness of screening OTUD6B in suspected Rubinstein-Taybi syndrome
      patients with negative results after the screening of the major genes
    explanation: >-
      The authors' own explicit reflex-testing recommendation, which is a
      diagnostic-pathway claim rather than a phenotype claim.
  - reference: PMID:38389298
    reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      previous publications have reported an initial clinical suspicion for
      Kabuki syndrome (KS) in some affected individuals
    explanation: >-
      Documents that the Kabuki misdirection has actually occurred in practice,
      supporting the second half of the reflex-testing recommendation.
treatments:
- name: Antiseizure Pharmacotherapy
  description: >-
    Seizures are managed with standard antiseizure medication. Valproate was used to
    treat generalized tonic-clonic seizures in a reported individual with biallelic
    OTUD6B splice variants. There is no disorder-specific antiseizure protocol and no
    evidence that any particular agent is preferred in OTUD6B-related disease; drug
    choice follows general pediatric epilepsy practice and seizure semiology.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: valproic acid
      term:
        id: CHEBI:39867
        label: valproic acid
  evidence:
  - reference: PMID:30364145
    reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      At 5 years, tonic-clonic seizures occurred, thus valproate treatment was
      started.
    explanation: >-
      Documents actual antiseizure pharmacotherapy in a genetically confirmed
      individual.
- name: Levothyroxine Replacement for Hypothyroidism
  description: >-
    Hypothyroidism recurs in unrelated affected individuals and is the one
    genuinely treatable manifestation of this disorder, which is why endocrine
    surveillance is recommended in the first place. Standard thyroid hormone
    replacement is used; nothing about the OTUD6B genotype changes the drug or
    the monitoring. In the reported Chinese case, levothyroxine was started in
    the week the newborn metabolic screen returned, and by 3 years 6 months the
    dose had been titrated down with thyroid function in the normal range on
    every check, so this is a treatment with a documented biochemical response
    in a genetically confirmed individual.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: levothyroxine
      term:
        id: CHEBI:18332
        label: L-thyroxine
  evidence:
  - reference: PMID:41188742
    reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      She started levothyroxine sodium tablets that same week.
    explanation: >-
      Documents actual levothyroxine therapy in a genetically confirmed
      individual with OTUD6B-related hypothyroidism.
  - reference: PMID:41188742
    reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      At her last visit, age 3 years 6 months, the dose was down
      to 12.5  µg daily, with every thyroid check since 3monts
      age within the normal range.
    explanation: >-
      Records the biochemical response and dose titration on follow-up. Quoted
      verbatim from the cached full text including its typographic artifacts
      ("3monts"), per the never-retype rule.
- name: Endocrine and Immunologic Surveillance
  description: >-
    Because hypothyroidism and hypogammaglobulinemia have recurred in unrelated
    affected individuals and both are treatable, thyroid function testing and
    immunoglobulin quantification are recommended at diagnosis and on follow-up.
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:32924626
    reference_title: "Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the third patient with associated hypothyroidism and hypogammaglobulinemia,
      underscoring the value of screening for these conditions in other patients
    explanation: >-
      The authors explicitly recommend screening for these two treatable
      comorbidities in other affected individuals.
- name: Multidisciplinary Supportive Care
  description: >-
    Management is supportive and symptom-directed: seizure control, nutritional and
    feeding support for poor growth and feeding difficulty, developmental and
    rehabilitative therapies, cardiac evaluation for congenital heart disease, and
    dental care for the orodental phenotype. There is no disease-modifying therapy.
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:32924626
    reference_title: "Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The current challenge with this patient is to ensure medical management of his
      seizures and provide him with a better quality of life.
    explanation: >-
      Characterizes present-day management as symptomatic and quality-of-life
      focused rather than disease-modifying.
  - reference: PMID:32924626
    reference_title: "Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The possibilities of additional therapeutic approaches may increase by
      understanding the physiopathology of the involved pathways.
    explanation: >-
      States that mechanism-targeted therapy does not yet exist and remains
      aspirational.
- name: Genetic Counseling and Carrier Testing
  description: >-
    Autosomal recessive inheritance gives a 25 percent sibling recurrence risk.
    Counseling should cover the recessive model, carrier testing of parents and
    at-risk relatives, and the option of prenatal or preimplantation testing once the
    familial variants are known. Consanguinity is common in reported families, and
    the RP1L1 experience in PMID:34354232 shows that a second independent recessive
    disorder can co-segregate and confound the phenotype, so exome or genome data
    should be reanalyzed in depth in consanguineous pedigrees.
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:34354232
    reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      demonstrating the need for in-depth analysis of WES data in consanguineous
      families to uncover simultaneous autosomal recessive disorders
    explanation: >-
      Directly supports the counseling and reanalysis recommendation for
      consanguineous families.
differential_diagnoses:
- name: BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies
  disease_term:
    preferred_term: BPTF-related neurodevelopmental disorder (NEDDFL)
    term:
      id: MONDO:0060596
      label: neurodevelopmental disorder with dysmorphic facies and distal limb anomalies
  description: >-
    A distinct autosomal dominant entity (MONDO:0060596, OMIM:617755) caused by
    heterozygous variants in BPTF (hgnc:3581). Its MONDO label differs from this
    disorder's by two words, which makes it the single most likely entity to be
    conflated with OTUD6B disease in a text or label-based search.
  distinguishing_features:
  - >-
    Molecular: BPTF (hgnc:3581) heterozygous, autosomal dominant and typically de
    novo, versus OTUD6B (hgnc:24281) biallelic and autosomal recessive. The
    inheritance mode alone separates them in almost every family.
  - >-
    Nomenclature: the near-identical MONDO labels are the hazard, not the
    phenotypes. Confirm the causative gene before importing any cohort data
    published under the "dysmorphic facies and distal limb anomalies" phrasing.
  notes: >-
    PMID:33522091 is cited here, and only here. It is a 25-individual NEDDFL
    cohort and it is exactly the kind of paper a label-based search would sweep
    into this entry by mistake; recording it against the differential is the
    honest place for it, and none of its phenotype data is used anywhere in the
    OTUD6B sections.
  evidence:
  - reference: PMID:33522091
    reference_title: "Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Neurodevelopmental disorder with dysmorphic facies and distal limb
      anomalies (NEDDFL), defined primarily by developmental delay/intellectual
      disability, speech delay, postnatal microcephaly, and dysmorphic features,
      is a syndrome resulting from heterozygous variants in the dosage-sensitive
      bromodomain PHD finger chromatin remodeler transcription factor BPTF gene.
    explanation: >-
      Establishes in the source's own words that the near-identically labelled
      NEDDFL entity is caused by heterozygous BPTF variants, which is the
      molecular discriminator this differential turns on.
- name: ZMIZ1-related neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies
  disease_term:
    preferred_term: ZMIZ1-related neurodevelopmental disorder (NEDDFSA)
    term:
      id: MONDO:0032855
      label: neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies
  description: >-
    A distinct autosomal dominant entity (MONDO:0032855, OMIM:618659) caused by
    heterozygous variants in ZMIZ1 (hgnc:16493). Its label differs from this
    disorder's only in "skeletal" versus "limb". This is not only a label
    hazard: PMID:34680978 reports a proband who genuinely carries variants in
    both genes, so the two entities can co-occur in one patient.
  distinguishing_features:
  - >-
    Molecular: ZMIZ1 (hgnc:16493) heterozygous and autosomal dominant, versus
    biallelic recessive OTUD6B. ZMIZ1 is a transcriptional coregulator, not a
    deubiquitinase, so there is no shared mechanism to justify pooling evidence.
  - >-
    Co-occurrence, not just confusion: in PMID:34680978 the same 5-year-old girl
    carries a hemizygous OTUD6B c.873delA over a paternal 8q21.3 whole-gene
    deletion AND a heterozygous ZMIZ1 c.1491 + 2T > C splice variant confirmed by
    mRNA study to skip exon 14. Her Williams syndrome-like facial features
    (periorbital edema, hanging cheek, long and smooth philtrum) and her
    polydactyly are curated in this entry with supports PARTIAL for exactly this
    reason. Finding a ZMIZ1 variant therefore does not exclude OTUD6B disease,
    and vice versa.
  notes: >-
    Cross-reference: the phenotypes Periorbital Edema, Hanging Cheek, Long
    Philtrum, Smooth Philtrum, and Polydactyly in this entry all derive from the
    dual-locus PMID:34680978 proband and all name this differential in their
    attribution notes.
  evidence:
  - reference: PMID:34680978
    reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The OTUD6B and ZMIZ1 genes were recently identified as causes of syndromic
      intellectual disability (ID) with shared phenotypes of facial dysmorphism,
      distal limb anomalies, and seizure disorders.
    explanation: >-
      States the phenotypic overlap that makes ZMIZ1 a differential for this
      disorder, in the authors' own words.
  - reference: PMID:34680978
    reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      OTUD6B- and ZMIZ1-related ID are inherited in autosomal recessive and
      autosomal dominant patterns, respectively.
    explanation: >-
      Sources the inheritance-mode discriminator that separates the two entities
      in nearly every family.
  - reference: PMID:34680978
    reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This ZMIZ1 variant yielded exon 14 skipping, as evidenced by mRNA study.
    explanation: >-
      Functional confirmation that the second-locus ZMIZ1 allele in this proband
      is real and consequential, which is what makes it a genuine confounder for
      the facial phenotypes rather than an incidental finding.
- name: OTUD5-related multiple congenital anomalies syndrome
  disease_term:
    preferred_term: OTUD5-related multiple congenital anomalies-neurodevelopmental syndrome (MCAND)
    term:
      id: MONDO:0025351
      label: multiple congenital anomalies-neurodevelopmental syndrome, X-linked
  description: >-
    An X-linked disorder (MONDO:0025351, OMIM:301056) caused by hemizygous
    variants in OTUD5 (hgnc:25402), confirmed against the MONDO
    `RO:0004003` gene-association relation. OTUD5 is a member
    of the same OTU deubiquitinase family as OTUD6B, so the two share
    ubiquitin-signalling mechanism language and are frequently co-discussed in
    reviews of OTU-family disease.
  distinguishing_features:
  - >-
    Molecular: X-linked hemizygous OTUD5 in males, versus autosomal recessive
    biallelic OTUD6B in either sex.
  - >-
    Literature hazard: papers about "OTU deubiquitinase deficiency" may describe
    either gene. Check which gene the reported cohort actually carries variants
    in before citing it here.
- name: OTUD7A-related phenotypes and the 15q13.3 microdeletion syndrome
  disease_term:
    preferred_term: 15q13.3 microdeletion syndrome (the OTUD7A-containing interval)
    term:
      id: MONDO:0012774
      label: chromosome 15q13.3 microdeletion syndrome
  notes: >-
    The bound term is the contiguous-gene deletion syndrome (MONDO:0012774,
    OMIM:612001), not an OTUD7A gene-disease entity. MONDO carries no
    `RO:0004003` OTUD7A association on this term, and there is no separate clean
    MONDO entity for OTUD7A-related disease, so the deletion syndrome is the
    correct and only bindable target. The OTUD7A framing is retained in the
    description because the literature hazard is the gene-family adjacency, not
    the deletion syndrome's clinical picture.
  description: >-
    OTUD7A lies within the 15q13.3 microdeletion critical region and is another
    OTU-family gene implicated in neurodevelopmental disease, so it appears
    alongside OTUD6B in family-level reviews.
  distinguishing_features:
  - >-
    Molecular: a recurrent copy-number loss at 15q13.3 detected by
    chromosomal microarray, versus biallelic OTUD6B sequence variants detected
    by exome or gene-panel sequencing. Different assay, different mechanism.
references:
- reference: PMID:28343629
  title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
- reference: PMID:30364145
  title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
- reference: PMID:31147255
  title: "[First Spanish case of syndromic intellectual disability with dysmorphic facies, seizures, and distal limb anomalies caused by balletic mutations in the OTUD6B gene]."
- reference: PMID:32181568
  title: Phenotypic expansion of OTUD6B-related syndrome.
- reference: PMID:32924626
  title: "Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case."
- reference: PMID:34354232
  title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
- reference: PMID:34680978
  title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
- reference: PMID:35707595
  title: "A New Family with a Novel OTUD6B Mutation: Practicing Whole Exome Sequencing for Antenatal Diagnosis of Tetralogy of Fallot."
- reference: PMID:35430327
  title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
- reference: PMID:38389298
  title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
- reference: PMID:41188742
  title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
- reference: PMID:27864334
  title: Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation.
- reference: PMID:33421002
  title: Studying OTUD6B-OTUB1 Protein-Protein Interaction by Low-Throughput GFP-Trap Assays and High-Throughput AlphaScreen Assays.
- reference: PMID:33522091
  title: "Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies."
📚

References & Deep Research

References

14
Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features.
No top-level findings curated for this source.
First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features.
No top-level findings curated for this source.
[First Spanish case of syndromic intellectual disability with dysmorphic facies, seizures, and distal limb anomalies caused by balletic mutations in the OTUD6B gene].
No top-level findings curated for this source.
Phenotypic expansion of OTUD6B-related syndrome.
No top-level findings curated for this source.
Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case.
No top-level findings curated for this source.
OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype.
No top-level findings curated for this source.
Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability.
No top-level findings curated for this source.
A New Family with a Novel OTUD6B Mutation: Practicing Whole Exome Sequencing for Antenatal Diagnosis of Tetralogy of Fallot.
No top-level findings curated for this source.
Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations.
No top-level findings curated for this source.
Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review.
No top-level findings curated for this source.
Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case.
No top-level findings curated for this source.
Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation.
No top-level findings curated for this source.
Studying OTUD6B-OTUB1 Protein-Protein Interaction by Low-Throughput GFP-Trap Assays and High-Throughput AlphaScreen Assays.
No top-level findings curated for this source.
Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies.
No top-level findings curated for this source.

Deep Research

1
Claude Code
OTUD6B‑Related Neurodevelopmental Disorder (IDDFSDA) — Comprehensive Research Report
claude-haiku-4-5-20251001, claude-opus-5[1m] 40 citations 2026-08-01T00:53:08.737317

OTUD6B‑Related Neurodevelopmental Disorder (IDDFSDA) — Comprehensive Research Report

Prepared: 2026‑08‑01 · Target entity: OTUD6B‑Related Neurodevelopmental Disorder · MONDO:0044319


⚠️ Curation Preflight Notes (read before using this report)

Three disambiguation hazards apply to this entity and should be treated as Named Entity Confusion (NEC) risk per the dismech DR SOP:

  1. OTUD6B-AS1 is a different molecular entity. Of ~76 PubMed records for "OTUD6B," the large majority (≈40) concern OTUD6B‑AS1, a long non‑coding antisense RNA transcribed at the same 8q21.3 locus, studied almost exclusively as a cancer biomarker (breast, colorectal, cervical, thyroid, bladder). None of these bear on the neurodevelopmental disorder. Do not cite OTUD6B‑AS1 papers as OTUD6B evidence.
  2. OTUD7A is a different DUB / different NDD gene. OTUD7A (15q13.3 microdeletion driver, MIM 612024) also causes a DUB‑related NDD with epilepsy and ID (PMID:36604605). It is a sister-gene confusion, not the same disease.
  3. OTUD6A is a paralog at Xq26.1, not currently a Mendelian disease gene.

MONDO identity anchors verified: MONDO:0044319 carries xrefs OMIM:617452, Orphanet:505237, GARD:0017942, MEDGEN:1375601, UMLS:C4479520, and sits under MONDO:0000508 (syndromic intellectual disability) — matching the ClinGen gene‑disease validity assertion (below). Causal gene = OTUD6B. Preflight passes.

Protein numbering discrepancy to resolve before curating catalytic residues: UniProt canonical Q8N6M0 is a 293‑aa protein with the OTU domain at residues 147–284 and catalytic residues Cys158 (nucleophile) / His277. The original AJHG paper's full text (per PMC5384096) describes a 323‑aa protein with a predicted active site of "Asp185, Cys188, and His307" — an offset consistent with a longer alternative isoform's numbering. All clinically reported variants use NM_016023.5 / 293‑aa numbering (e.g., p.Lys291AsnfsTer3 is near the C‑terminus of a 293‑aa protein). Anchor on the 293‑aa numbering; flag the 323‑aa figures as isoform‑dependent.

Verbatim status of quotations below: Abstract text marked with > block quotes was retrieved verbatim from PubMed record pages and is suitable for evidence snippet: use after just fetch-reference + just validate-references. Figures attributed to PMC5384096 full text were extracted by an automated reader and are paraphrase-risk — verify against the article before using as snippets.


1. Disease Information

1.1 Overview

OTUD6B‑related neurodevelopmental disorder is a rare autosomal recessive multisystem developmental disorder caused by biallelic loss‑of‑function variants in OTUD6B, which encodes an ovarian‑tumour (OTU)‑domain deubiquitinating enzyme. The core phenotype is global developmental delay and intellectual disability with early‑onset seizures, a recognizable dysmorphic facial gestalt, and distal limb anomalies (notably broad distal phalanges/thumbs with persistent fetal fingertip pads). Prenatal‑onset growth restriction, microcephaly, hypotonia, feeding difficulty, structural brain anomalies, and congenital heart disease are frequent. Severity is strikingly bimodal: predicted‑null biallelic genotypes produce a severe, often non‑ambulatory, non‑verbal, gastrostomy‑dependent phenotype, whereas hypomorphic missense/leaky‑splice genotypes may produce only mild‑to‑moderate ID with preserved speech and ambulation.

The disorder was defined in 2017 by Santiago‑Sim et al. in the American Journal of Human Genetics (PMID:28343629), with 12 individuals from 6 families:

Ubiquitination is a posttranslational modification that regulates many cellular processes including protein degradation, intracellular trafficking, cell signaling, and protein-protein interactions. Deubiquitinating enzymes (DUBs), which reverse the process of ubiquitination, are important regulators of the ubiquitin system. OTUD6B encodes a member of the ovarian tumor domain (OTU)-containing subfamily of deubiquitinating enzymes. Herein, we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6 independent families with an intellectual disability syndrome associated with seizures and dysmorphic features. In subjects with predicted loss-of-function alleles, additional features include global developmental delay, microcephaly, absent speech, hypotonia, growth retardation with prenatal onset, feeding difficulties, structural brain abnormalities, congenital malformations including congenital heart disease, and musculoskeletal features. Homozygous Otud6b knockout mice were subviable, smaller in size, and had congenital heart defects, consistent with the severity of loss-of-function variants in humans. Analysis of peripheral blood mononuclear cells from an affected subject showed reduced incorporation of 19S subunits into 26S proteasomes, decreased chymotrypsin-like activity, and accumulation of ubiquitin-protein conjugates. Our findings suggest a role for OTUD6B in proteasome function, establish that defective OTUD6B function underlies a multisystemic human disorder, and provide additional evidence for the emerging relationship between the ubiquitin system and human disease. — Santiago‑Sim T et al., Am J Hum Genet 2017;100(4):676‑688. doi:10.1016/j.ajhg.2017.03.001 (PMID:28343629)

1.2 Key identifiers

Resource Identifier Label
MONDO MONDO:0044319 intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies
OMIM (phenotype) #617452 INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES; IDDFSDA
OMIM (gene) *612021 OTU DOMAIN‑CONTAINING PROTEIN 6B; OTUD6B
Orphanet ORPHA:505237 Early‑onset seizures–distal limb anomalies–facial dysmorphism–global developmental delay syndrome
ICD‑10 Q87.8 Other specified congenital malformation syndromes NEC (via Orphanet mapping)
ICD‑11 no dedicated code; nearest is LD2F "syndromes with intellectual disability as a major feature" (⚠️ not independently verified)
MedGen / UMLS C4479520 (MedGen UID 1375601)
GARD GARD:0017942
HGNC (gene) HGNC:24281 (dismech form: hgnc:24281) OTU deubiquitinase 6B
Entrez Gene 51633
Ensembl ENSG00000155100
UniProt Q8N6M0 Deubiquitinase OTUD6B
RefSeq transcript NM_016023.5 reference transcript used by ClinVar
Cytoband 8q21.3 GRCh38 chr8:91,070,196–91,087,095

1.3 Synonyms and alternative names

  • IDDFSDA (OMIM acronym)
  • OTUD6B‑related syndrome / OTUD6B‑related disorder / OTUD6B‑associated intellectual disability
  • Intellectual disability syndrome with seizures and dysmorphic features
  • Early‑onset seizures–distal limb anomalies–facial dysmorphism–global developmental delay syndrome (Orphanet preferred term)

Gene aliases: CGI-77, DUBA5; previous HGNC symbol "OTU domain containing 6B".

1.4 Information provenance

This is an aggregated disease‑level entity, not an EHR‑derived one. The knowledge base is built entirely from published case reports and small family series (n ≈ 28–30 individuals worldwide as of 2025), plus curated aggregators (OMIM, Orphanet, ClinGen, HPO, ClinVar). There is no registry, no natural‑history cohort, and no EHR phenotype algorithm for this disorder. The 2025 BMC Pediatrics report states verbatim:

There have been < 30 reported cases globally without fundus and retinal lesions. — Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case. BMC Pediatr. 2025 Nov 4;25(1):905 (PMID:41188742, PMC12584513)


2. Etiology

2.1 Disease causal factors

Single, monogenic cause: biallelic (homozygous or compound heterozygous) pathogenic variants in OTUD6B. No environmental, infectious, or multifactorial etiology has been described or is biologically plausible for this entity. The etiologic mechanism is loss of function of the OTUD6B deubiquitinase, with resulting perturbation of ubiquitin‑dependent proteostasis — specifically 26S proteasome assembly/activity — during embryonic and postnatal development.

2.2 Risk factors

Genetic (causal): - Two pathogenic OTUD6B alleles. Reported allele classes: nonsense, frameshift, canonical splice‑site (with demonstrated aberrant splicing), and rare missense variants localized to the OTU catalytic domain. - Consanguinity is the dominant risk amplifier. Reported families are overwhelmingly consanguineous — Turkish, Egyptian (two unrelated families, PMID:34354232), Saudi/Gulf, Mexican, Spanish, Italian, Chinese. Founder/recurrent alleles: c.433C>T (p.Arg145*) was homozygous in three of the six original families and independently in the Mexican proband, consistent with either a recurrent CpG transition or a shared haplotype. - Second‑locus / blended phenotypes — an under‑appreciated etiologic modifier in this disorder. Three published probands carry a second pathogenic locus that contributes phenotype: a homozygous RP1L1 nonsense variant causing retinal degeneration in Egyptian Family I (PMID:34354232); a heterozygous PKD1 variant contributing renal cystic disease alongside Tetralogy of Fallot (PMID:35707595); and a ZMIZ1 splice variant co‑occurring with an OTUD6B point mutation + 8q21.3 microdeletion (PMID:34680978).

Environmental risk factors: none identified. No toxin, exposure, maternal factor, parity, or ascertainment‑independent sex effect has been reported.

Age/sex: onset is congenital‑to‑infantile in all reported cases. No sex bias is expected (autosomal recessive); reported cohorts include both sexes with no reported skew, though n is far too small to test.

2.3 Protective factors

  • Genetic: the only demonstrated modifier of severity is residual OTUD6B activity. Hypomorphic missense alleles and leaky splice alleles are associated with markedly milder disease. Two structural‑modelling studies make this explicit — PMID:35430327 concluded that p.Tyr216Cys (milder phenotype) causes "localized destabilization" whereas p.Ile274Arg (severe phenotype) causes "significant distortion in the overall fold of OTUD6B." Similarly, PMID:30364145's Italian proband with two splice variants retained "less than 1% of wild-type transcripts" yet had only mild ID — indicating that the genotype–severity map is not fully resolved and that trace residual protein may be disproportionately protective (or that other modifiers exist).
  • Environmental protective factors: none identified. Standard heterozygote carriers are unaffected (pLI 0; see §4.2).

2.4 Gene–environment interactions

None established. One clinically relevant gene–physiology interaction is worth flagging for the pathograph: the Chinese proband's seizures were febrile ("two episodes of febrile seizure" at 13 and 17 months, PMID:41188742) — raising a hypothesis, currently unsupported by cohort data, that intercurrent illness/pyrexia lowers seizure threshold in this proteostasis disorder. This should be curated at most as a KNOWLEDGE_GAP discussion, not as an asserted mechanism.


3. Phenotypes

3.1 Authoritative HPO annotation set (OMIM:617452)

Retrieved from https://ontology.jax.org/api/network/annotation/OMIM:617452. Frequencies are the HPOA n/m counts, derived from the 12‑individual founding cohort (PMID:28343629) except cardiac terms, which are n/6.

HPO ID Term Frequency Notes
HP:0010864 Severe intellectual disability 12/12 (100%) Core; but see §3.3 — milder alleles give mild/moderate ID
HP:0001250 Seizure 12/12 (100%) Early‑onset
HP:0001263 Global developmental delay (not quantified) Universal
HP:0000252 Microcephaly 9/12 (75%) Onset HP:0003593 (Infantile onset)
HP:0002194 Delayed gross motor development 9/12 (75%) Onset HP:0003593
HP:0000750 Delayed speech and language development 9/12 (75%) Absent speech in the severe group
HP:0001290 Generalized hypotonia 9/12 (75%)
HP:0011968 Feeding difficulties 9/12 (75%) G‑tube dependence in severe cases
HP:0001511 Intrauterine growth retardation 7/12 (58%) Onset HP:0030674 (Antenatal onset)
HP:0004322 Short stature 7/12 (58%)
HP:0000343 Long philtrum 7/12 (58%) Facial gestalt
HP:0000400 Macrotia 7/12 (58%) Facial gestalt
HP:0011304 Broad thumb 6/12 (50%) Distal limb anomaly
HP:0004325 Decreased body weight 6/12 (50%)
HP:0000219 Thin upper lip vermilion 6/12 (50%) Facial gestalt
HP:0000637 Long palpebral fissure 6/12 (50%) Kabuki‑overlap feature
HP:0000426 Prominent nasal bridge 5/12 (42%) Facial gestalt
HP:0002650 Scoliosis 5/12 (42%)
HP:0000278 Retrognathia 4/12 (33%)
HP:0001845 Overlapping toe 3/12 (25%)
HP:0000729 Autistic behavior 3/12 (25%)
HP:0002079 Hypoplasia of the corpus callosum 3/12 (25%) Brain MRI
HP:0000470 Short neck 3/12 (25%)
HP:0002553 Highly arched eyebrow 3/12 (25%) Kabuki‑overlap feature
HP:0200021 Down‑sloping shoulders 3/12 (25%)
HP:0001631 Atrial septal defect 3/6 (50%) Cardiac
HP:0001629 Ventricular septal defect 2/6 (33%) Cardiac; matches the mouse
HP:0002510 Spastic tetraplegia 2/12 (17%) Severe group
HP:0012450 Chronic constipation 2/12 (17%)
HP:0000960 Sacral dimple 2/12 (17%)
HP:0000248 Brachycephaly 1/12 (8%)
HP:0000007 Autosomal recessive inheritance Inheritance term

Annotated without frequency: HP:0002119 Ventriculomegaly · HP:0002540 Inability to walk · HP:0001508 Failure to thrive · HP:0001371 Flexion contracture · HP:0000028 Cryptorchidism · HP:0000369 Low‑set ears · HP:0000411 Protruding ear · HP:0000377 Abnormal pinna morphology · HP:0000365 Hearing impairment · HP:0001276 Hypertonia · HP:0000527 Long eyelashes · HP:0000218 High palate · HP:0000276 Long face · HP:0000494 Downslanted palpebral fissures · HP:0005469 Flat occiput · HP:0000431 Wide nasal bridge · HP:0001762 Talipes equinovarus · HP:0001182 Tapered finger.

3.2 Post‑2017 phenotypic expansions (each from a specific report)

Feature Source Suggested HPO (⚠️ verify with just validate-terms)
Persistent fetal fingertip pads; broad distal phalanges of thumbs and halluces with prominent interphalangeal joints — called pathognomonic PMID:34354232 (verbatim: "Broad distal phalanges (especially the thumbs and halluces) with prominent interphalangeal joints and fetal pads were recognized in all patients and hence considered pathognomonic.") HP:0001212 Prominent fingertip pads; HP:0011304 Broad thumb; HP:0010511 Broad hallux
Orodental features: macrodontia, dental crowding, abnormally shaped teeth, thick alveolar ridges PMID:34354232 (verbatim: "various orodental features were present including macrodontia, dental crowding, abnormally shaped teeth, and thick alveolar ridges") HP:0001572 Macrodontia; HP:0000678 Dental crowding; HP:0006482 Abnormal dental morphology
Delayed eruption of primary dentition; soft doughy skin with reduced sweating; mirror movements PMID:38389298 (verbatim: "previously unreported clinical manifestations such as delayed eruption of primary dentition, soft doughy skin with reduced sweating, and mirror movements present in our patients suggest an expansion of the phenotype") HP:0000680 Delayed eruption of teeth; HP:0000966 Hypohidrosis; HP:0004302 Mirror movements
Hypothyroidism and hypogammaglobulinemia — third reported patient with both PMID:32924626 (verbatim: "this is the third patient with associated hypothyroidism and hypogammaglobulinemia, underscoring the value of screening for these conditions in other patients") HP:0000821 Hypothyroidism; HP:0004313 Decreased circulating antibody level
Ocular developmental anomalies: nystagmus, optic disc hypoplasia, retinal abnormalities — first report PMID:41188742 (verbatim: "Significantly, none of the 27 previously reported IDDFSDA cases exhibited ocular developmental abnormalities.") HP:0000639 Nystagmus; HP:0000609 Optic nerve hypoplasia
Tetralogy of Fallot (index case + a prior medically terminated pregnancy in the same family) PMID:35707595 HP:0001636 Tetralogy of Fallot
Renal parenchymal disease with simple cortical cysts (blended with a heterozygous PKD1 variant) PMID:35707595 HP:0000107 Renal cyst
Williams‑syndrome‑like facial features: periorbital edema, hanging cheek, long smooth philtrum; polydactyly PMID:34680978 (verbatim: "We suggest that Williams syndrome-like phenotypes, namely, periorbital edema, hanging cheek, and long and smooth philtrum represent expanded phenotypes of OTUD6B-related ID.") HP:0100539 Periorbital edema; HP:0000174 Abnormality of the palate; HP:0010442 Polydactyly
Vertebral anomaly PMID:38389298 HP:0003468 Abnormal vertebral morphology (⚠️ verify)
Brain MRI: white matter abnormalities, cortical atrophy (in addition to hypoplastic CC and ventriculomegaly) Orphanet ORPHA:505237 summary HP:0002500 Abnormal cerebral white matter morphology; HP:0002059 Cerebral atrophy
Abnormal cytoplasmic inclusions in lymphocytes (cellular phenotype) PMC5384096 full text (⚠️ paraphrase‑risk) no direct HPO; curate as category: Cellular

3.3 Phenotype characteristics

Age of onset. Congenital‑to‑infantile. Prenatal onset is documented in a substantial minority: IUGR is annotated with HPO onset term HP:0030674 (Antenatal onset) at 7/12, and one family had a pregnancy medically terminated for antenatally diagnosed Tetralogy of Fallot (PMID:35707595). Microcephaly and motor delay carry HPO onset HP:0003593 (Infantile onset). Orphanet records age of onset as infancy. GARD summarizes symptom emergence at 1–23 months.

Severity — a genuinely bimodal distribution. This is the single most curation‑relevant characteristic of the disorder and should be modelled as has_subtypes or at minimum as an explicit severity axis: - Severe (predicted‑null biallelic genotypes): microcephaly, absent speech, inability to walk, feeding‑tube dependence, spastic quadriplegia. MedGen summarizes: "The most severely affected patients have a neurodevelopmental disorder with microcephaly, absent speech, and inability to walk, and they require feeding tubes." - Mild (hypomorphic missense / leaky splice): "less severely affected individuals have mild to moderate intellectual disability with normal speech and motor development." The Italian proband (PMID:30364145) is the archetype — "mild intellectual disability, speech and motor delay, and recurrent seizures."

PMID:35430327 makes the genotype→severity link explicit and computational: "our findings support that the clinical severity could be related with the predicted functional severity of the variations in OTUD6B."

Critically, intra‑familial variability also exists — PMID:34354232: "our patients showed inter- and intrafamilial differences with regard to the clinical and brain imaging findings." This argues against a purely genotype‑determined severity model and supports curating an unresolved modifier gap.

Progression. No natural‑history study exists. The disorder is best characterized as a static (non‑degenerative) encephalopathy with a congenital structural/developmental basis — brain MRI shows malformation (corpus callosum hypoplasia, ventriculomegaly) rather than progressive atrophy in most reports, though cortical atrophy is listed by Orphanet. Seizures are recurrent/episodic on a chronic lifelong background. Scoliosis and contractures are expected to be progressive secondary orthopedic complications of hypotonia/spasticity. This progression characterization is an inference from the reported feature set, not a cited finding — flag as a knowledge gap.

Frequency evidence discipline. Per docs/frequency-evidence-guidelines.md, the HPOA n/12 counts are derived counts from the founding cohort and are acceptable justification for FrequencyEnum bands. However, they reflect a single ascertainment‑biased cohort of predominantly severe cases; frequencies for the mild end of the spectrum are almost certainly overstated (e.g., "Severe intellectual disability 12/12" is contradicted by later mild cases). Recommend curating the HPOA frequencies with an explicit note, or omitting frequency: for terms where the 2018–2025 literature conflicts with the 2017 cohort.

Quality of life. No EQ‑5D, PROMIS, SF‑36, or disease‑specific QoL instrument has been applied. The only QoL statement in the literature is a clinical aspiration, from PMID:32924626: "The current challenge with this patient is to ensure medical management of his seizures and provide him with a better quality of life." Expected QoL burden is dominated by (a) refractory seizures, (b) non‑verbal status and total care dependence in the severe group, (c) feeding‑tube dependence, and (d) caregiver burden. Mark as a knowledge gap.


4. Genetic / Molecular Information

4.1 Causal gene

OTUD6B (hgnc:24281; OMIM *612021; Entrez 51633; Ensembl ENSG00000155100; UniProt Q8N6M0), 8q21.3, reference transcript NM_016023.5. Encodes a 293‑aa cysteine‑protease deubiquitinase of the OTU family.

UniProt Q8N6M0 FUNCTION comment (verbatim):

[Isoform 1]: Deubiquitinating enzyme that may play a role in the ubiquitin-dependent regulation of protein synthesis, downstream of mTORC1. May associate with the protein synthesis initiation complex and modify its ubiquitination to repress translation. May also repress DNA synthesis and modify different cellular targets thereby regulating cell growth and proliferation. May also play a role in proteasome assembly and function. [Isoform 2]: Stimulates protein synthesis. Influences the expression of CCND1/cyclin D1 by promoting its translation and regulates MYC/c-Myc protein stability.

Domain architecture: N‑terminal coiled‑coil region + OTU catalytic domain, residues 147–284. Catalytic triad residues: Cys155/Cys158 (Cys158 is the nucleophile), His277. Cys→Ser mutation of the nucleophile abolishes DUB activity (functionally demonstrated in PMID:21267069: "Mutation of the conserved Cys residue abolished its deubiquitinating activity in vitro.").

Two functionally opposed splice isoforms. Isoform 2 (OTUD6B‑2) differs by replacement of residues 1–105 with "MISK." This is not a curatorial footnote — the isoforms have antagonistic effects on translation (PMID:27864334, §6.2), which is relevant to interpreting variant consequence: a variant in exon 1–3 may affect only OTUD6B‑1.

4.2 Gene constraint (gnomAD v4.0, via ClinGen)

Metric Value Interpretation
pLI 0 Not LoF‑intolerant in the heterozygous state
LOEUF 1.48 Far above the 0.35 haploinsufficiency threshold
DECIPHER %HI 30.63 Moderate, but not a haploinsufficiency signal

These metrics are exactly what is expected for a recessive disease gene and should not be read as evidence against pathogenicity. Heterozygous carriers (including all obligate parents in the reported families) are unaffected. This is an important curation point: an automated pipeline keying on pLI would incorrectly deprioritize OTUD6B.

4.3 ClinGen gene–disease validity

Classification: DEFINITIVE. ClinGen (search.clinicalgenome.org/kb/genes/HGNC:24281) records one gene‑disease validity assertion:

  • Gene: OTUD6B (HGNC:24281)
  • Disease: syndromic intellectual disability (MONDO:0000508)
  • Mode of inheritance: Autosomal recessive
  • Classification: Definitive
  • Expert panel: Intellectual Disability and Autism Gene Curation Expert Panel
  • Date: 2024‑08‑22

No ClinGen dosage‑sensitivity, actionability, or variant‑pathogenicity curations exist for this gene. No CPIC/PharmGKB records. → A CGGV: structured‑source citation should be retrievable for this assertion via just clingen-refresh / just clingen-list.

4.4 Reported pathogenic variants (literature)

All in NM_016023.5 numbering. Zygosity as reported.

cDNA Protein Class Zygosity Family / population Source
c.433C>T p.Arg145* nonsense homozygous Families 1, 2, 3 (2017 cohort); independently the first Mexican proband PMID:28343629; PMID:32924626
c.469_473delTTAAC p.Leu157Argfs*8 frameshift homozygous Family 4 (2017) PMID:28343629
c.173−2A>G — (splice acceptor) canonical splice homozygous Family 5 (2017) PMID:28343629
c.647A>G p.Tyr216Cys missense (OTU domain) homozygous Family 6 (2017); milder phenotype PMID:28343629; modelled PMID:35430327
c.324+1G>C splice donor, exon 2 compound het (with below) Italian proband; mild ID PMID:30364145
c.405+1G>A splice donor, exon 3 compound het (with above) Italian proband PMID:30364145
c.271C>T p.Gln91Ter nonsense homozygous Egyptian Family I PMID:34354232
c.767G>T p.Gly256Val missense (OTU domain) homozygous Egyptian Family II PMID:34354232
c.873delA p.Lys291AsnfsTer3 frameshift hemizygous (in trans with a paternal 0.118 Mb 8q21.3 deletion, chr8:92,084,087–92,202,189) 5‑yr‑old girl; also carried ZMIZ1 c.1491+2T>C PMID:34680978
c.815T>G p.Ile272Arg missense (OTU domain) homozygous Tetralogy of Fallot proband; also het PKD1 variant PMID:35707595
p.Ile274Arg (cDNA not stated in abstract) p.Ile274Arg missense (OTU domain) compound het with a novel frameshift severe IDDFSDA index case PMID:35430327
c.479A>G p.Tyr160Cys missense (likely pathogenic) compound het (with below) first Chinese case; ocular anomalies + hypothyroidism PMID:41188742
c.83−1delG — (splice acceptor) pathogenic splice compound het (with above) first Chinese case PMID:41188742
(2 variants, not specified in abstract) biallelic 3 siblings, Kabuki‑syndrome‑like presentation PMID:38389298
(not specified in abstract) biallelic first Spanish case PMID:31147255

ClinVar (NM_016023.5) additional P/LP small variants not tied to a specific publication above, confirmed by esummary: - c.287del (p.Pro96fs) — Pathogenic — IDDFSDA - c.776C>G (p.Ser259Ter) — Pathogenic - c.381_388del (p.Leu127fs) — Pathogenic — IDDFSDA - c.401A>G (p.Glu134Gly) — Likely pathogenic — IDDFSDA - c.83-1del — Pathogenic — IDDFSDA (matches PMID:41188742)

ClinVar counts (2026‑08‑01, via E‑utilities): 151 total records for OTUD6B; 54 records classified P/LP. Important caveat: the majority of the 54 are large chromosome‑8 copy‑number gains/losses that merely span the locus, not gene‑level small variants. The number of distinct P/LP small OTUD6B variants is on the order of 10–15. Do not cite "54 pathogenic OTUD6B variants" without this qualification.

Variant spectrum summary: - Class distribution: nonsense ≈ 4; frameshift ≈ 4; canonical splice ≈ 4; missense ≈ 5 (all within or adjacent to the OTU domain: Tyr160, Tyr216, Gly256, Ile272/274 — plus Glu134 just N‑terminal); one whole‑gene microdeletion in trans with a point mutation. - Missense clustering in the OTU domain (147–284) is a notable pattern supporting a domain‑restricted missense hotspot and useful for PM1‑type ACMG evidence. - Somatic vs germline: all disease variants are germline. Somatic OTUD6B alteration is not a described mechanism in this disorder; OTUD6B's cancer roles (§6.2) are expression‑level, not mutational. - Allele frequency: all reported disease alleles are absent or ultra‑rare in gnomAD. PMID:30364145 states verbatim: "Both variants are reported in the GnomAD database with a frequency lower than the 10‑5 and affect the donor splicing site, of exons 2 and 3, respectively." - Functional consequence: loss of function throughout. Nonsense/frameshift alleles are predicted to trigger NMD (explicitly modelled in PMID:35430327: "The truncating frameshift variant in one allele was predicted to undergo degradation via nonsense-mediated decay of the mRNA molecule."); splice alleles cause exon skipping with near‑total loss of wild‑type transcript; missense alleles cause fold destabilization of varying severity. No gain‑of‑function or dominant‑negative mechanism has been proposed.

4.5 Functional validation of splice variants

PMID:30364145 provides the strongest direct RNA evidence in the disorder:

RT-PCR experiments demonstrated that both variants affect OTUD6B splicing and lead to the production of aberrant transcripts, the major ones being, in both cases, the skipping of the upstream exon. Quantitative analysis performed by competitive-fluorescent RT-PCR on the patient RNA showed that the proband presents less than 1% of wild-type transcripts, further strengthening the causative role of these variants.

4.6 Modifier genes, epigenetics, chromosomal abnormalities

  • Modifier genes: none identified. The three "blended phenotype" second loci (RP1L1, PKD1, ZMIZ1) are independent co‑occurring conditions, not modifiers of the OTUD6B phenotype — PMID:34354232 is explicit that "Retinal degeneration, albeit present in both patients from Family I, was shown to be unrelated to OTUD6B." This is a valuable curation exemplar of DR‑style over‑attribution risk.
  • Epigenetics: No episignature has been published for OTUD6B‑related disorder. (Given the Kabuki‑syndrome mimicry documented in PMID:38389298 and PMID:30364145, this is a concrete, high‑value research gap — DNA‑methylation episignature classifiers already discriminate Kabuki syndrome, so an OTUD6B episignature would be a plausible diagnostic advance.) No data available.
  • Chromosomal abnormalities: one reported case with a 0.118 Mb paternally inherited deletion of 8q21.3 (chr8:92,084,087–92,202,189) encompassing OTUD6B, in trans with a maternal point mutation (PMID:34680978). This establishes that CMA can contribute the second hit and must be part of the diagnostic strategy (§10.2). Verbatim: "The CMA showed a paternally inherited 0.118 Mb deletion of 8q21.3, chr8:92084087-92202189, with OTUD6B involved."

5. Environmental Information

Not applicable. OTUD6B‑related neurodevelopmental disorder is a fully penetrant monogenic recessive condition. There are no reported environmental factors, lifestyle factors, toxicant exposures, or infectious agents that cause, trigger, or modify this disorder. No CTD/TOXNET association exists.

Two peripheral points worth recording as non‑etiologic: - The febrile trigger for the two seizures in the 2025 Chinese case (PMID:41188742) is a symptom‑precipitant observation, not an environmental etiology. - OTUD6B has documented antiviral innate‑immunity roles (§6.6). Whether patients with biallelic LoF have altered antiviral responses has not been tested in humans and must not be asserted. The reported hypogammaglobulinemia in three patients (PMID:32924626) is the only human immune signal.


6. Mechanism / Pathophysiology

6.1 The primary disease mechanism: impaired 26S proteasome assembly

This is the only mechanism established in patient material and should be the backbone of the pathograph.

Causal chain (patient‑derived, PMID:28343629):

Biallelic LoF OTUD6B variant  [MOLECULAR]
  → Loss of OTUD6B deubiquitinase activity  [MOLECULAR]
    → Reduced incorporation of 19S regulatory-particle subunits into 26S proteasomes;
      accumulation of 19S precursor complexes  [MOLECULAR]
      → Decreased 26S chymotrypsin-like peptidase activity  [MOLECULAR]
→ Accumulation of ubiquitin-protein conjugates; cytoplasmic inclusions in lymphocytes  [CELLULAR]
  → Impaired proteostasis in developing neural, cardiac and skeletal tissue  [TISSUE]
    → Multisystem developmental disorder  [ORGANISM]

The abstract‑level evidence sentence (verbatim, PMID:28343629): "Analysis of peripheral blood mononuclear cells from an affected subject showed reduced incorporation of 19S subunits into 26S proteasomes, decreased chymotrypsin-like activity, and accumulation of ubiquitin-protein conjugates."

Quantitative detail from the full text (PMC5384096) — ⚠️ paraphrase‑risk, verify before citing as snippets: - Native PAGE: "substantially reduced incorporation of Rpn5 and Rpt6 subunits into 26S proteasomes," with Rpn5 reduced by ~65% (heterozygote) and ~90% (homozygote) vs. wild‑type. - 26S chymotrypsin‑like activity reduced ~20% in homozygote vs. heterozygote. - "19S precursor complexes accumulate in both heterozygous and homozygous subjects but not in wild-type controls." - Ubiquitin‑protein conjugates "accumulated much stronger in the homozygous sample than in the heterozygous one." - Proposed mechanism (authors' speculation, flagged as such in the paper): "any impaired de-ubiquitination of proteasome subunits (including Rpn10, Rpn13, or Rpt5) might impact proteasome assembly and/or function," as "formation of 26S complexes is a process regulated by ubiquitin modification."

Note the gene‑dosage gradient: heterozygous carriers show intermediate biochemical abnormality (19S precursor accumulation, 65% Rpn5 reduction) while remaining clinically unaffected. This is a clean example of a biochemical phenotype that is subclinical in carriers — useful for a biochemical marker node with a carrier‑vs‑affected interpretation band.

6.2 Translation regulation downstream of mTORC1 (isoform‑opposed)

PMID:27864334 (in vitro, NSCLC cells) established the second major cellular function, verbatim:

Here, evidence is presented that the deubiquitinase OTUD6B regulates protein synthesis in non-small cell lung cancer (NSCLC) cells, operating downstream from mTORC1. OTUD6B associates with the protein synthesis initiation complex and modifies components of the 48S preinitiation complex. The two main OTUD6B splicing isoforms seem to regulate protein synthesis in opposing fashions: the long OTUD6B-1 isoform is inhibitory, while the short OTUD6B-2 isoform stimulates protein synthesis. […] OTUD6B-2 influences the expression of cyclin D1 by promoting its translation while regulating (directly or indirectly) c-Myc protein stability.

Relevance to the NDD: mTORC1‑coupled translational control is a canonical neurodevelopmental/epilepsy axis (cf. tuberous sclerosis, PMSE, focal cortical dysplasia). This provides a mechanistically coherent — but not experimentally demonstrated in neurons — bridge from OTUD6B loss to cortical malformation and seizure. Curate as a mechanistic_hypotheses entry with status: EMERGING, and attach the causal edge to that hypothesis group. Do not assert it as established human disease mechanism.

6.3 Cell‑cycle control (G1/S)

Two independent lines: - PMID:21267069 (mouse Ba/F3 cells + primary B lymphocytes): "Enforced expression of OTUD-6B in Ba/F3 cells could block cell proliferation by arresting cells in G1 phase. In addition, cyclin D2 level was down-regulated when OTUD-6B WT was overexpressed." Also documents post‑transcriptional control — Otud-6b mRNA is destabilized by tristetraprolin (TTP) via AU‑rich elements. - PMID:36059274 (multiple myeloma, EMBO J 2022): "we screened for DUB vulnerabilities in multiple myeloma […] and identified OTUD6B as an oncogene that drives the G1/S-transition. LIN28B, a suppressor of microRNA biogenesis, is specified as a bona fide cell cycle-specific substrate of OTUD6B. Stabilization of LIN28B drives MYC expression at G1/S, which in turn allows for rapid S-phase entry."

Note the direction conflict: OTUD6B overexpression is anti‑proliferative in B lymphocytes (2011) but pro‑proliferative via LIN28B‑MYC in myeloma (2022) and isoform‑dependent in NSCLC (2017). OTUD6B's proliferative effect is therefore context‑ and isoform‑dependent, and it is not safe to infer a single direction of effect on neural progenitor proliferation. This is a legitimate KNOWLEDGE_GAP for the NDD pathograph: does OTUD6B loss reduce or expand the neural progenitor pool, and is microcephaly proliferative or apoptotic in origin?

6.4 Stress granule dynamics via VCP/p97 — the most neurologically suggestive recent mechanism

PMID:41651815 (Cell Death Dis 2026), verbatim:

By combining interactomic and proximity proteomic approaches, we reveal that the deubiquitinating enzyme OTUD6B is associated with SG-related functions. Immunofluorescence assays showed that OTUD6B localized to SGs, as well as regulated their early assembly and clearance, partially dependent on its enzymatic activity. Further proximity proteomics and interactomics results uncover the ATPase VCP/p97, a key SG disassembly factor, as an OTUD6B-associated protein. OTUD6B and VCP association is governed through their disordered regions normally participated in biomolecular condensation. VCP knockdown or pharmacological inhibition phenocopied OTUD6B silencing by leading to defects in SG dynamics. […] Therefore, our findings establish OTUD6B as a critical modulator of SG dynamics, linking its function to stress responses and potential disease mechanisms.

The same abstract notes: "Impaired SG disassembly is closely implicated in neurodegenerative diseases and aging." Since VCP itself is a Mendelian neurodegeneration gene (MSP1/IBMPFD, ALS/FTD), an OTUD6B–VCP condensate axis is a plausible neural mechanism. Caveat: this work is in non‑neuronal cell lines and makes no claim about IDDFSDA. Curate as EMERGING hypothesis + IN_VITRO evidence source.

6.5 Enzyme‑independent scaffolding: the pVHL/HIF‑1α axis

PMID:32328410 (Adv Sci 2020) and PMID:32323143 (Protein Cell 2020) independently show OTUD6B stabilizes pVHL without using its catalytic activity, verbatim from PMID:32328410:

OTUD6B directly interacts with pVHL, decreases its ubiquitylation and proteasomal degradation to reduce HIF-1α accumulation in HCC cells under hypoxia. Surprisingly, OTUD6B limits the ubiquitylation of pVHL independent of its deubiquitylase activity. OTUD6B couples pVHL and elongin B/C to form more CBCVHL ligase complex, which protects pVHL from proteasomal degradation. […] Furthermore, OTUD6B gene is a direct transcriptional target of HIF-1α and upregulated upon hypoxia.

Curation implication: this is why catalytically‑dead missense variants may not fully phenocopy null alleles — OTUD6B has at least one non‑catalytic scaffolding function. This directly bears on interpreting the mild p.Tyr216Cys phenotype. It also predicts that OTUD6B loss should raise HIF‑1α — a testable but untested hypothesis in patient tissue.

6.6 Additional characterized functions (not established in the NDD)

Function Substrate/partner Evidence Species PMID
Type I IFN antiviral response — positive regulator IRF3 (removes K33‑linked polyUb at Lys315) in vitro + mouse human 37650650
Antiviral response — negative regulator irf3/irf7 (suppresses traf6‑mediated K63 polyUb) zebrafish KO, in vivo zebrafish 34183367
Centrosome clustering / mitotic fidelity KIFC1/HSET (prevents premature mitotic degradation) siRNA + CRISPR, TNBC human 39789388
DUB–DUB heterotypic interaction OTUB1 (first direct demonstration) GFP‑Trap + AlphaScreen human 33421002
Pulmonary arterial hypertension Calpain‑1/HIF‑1α rodent rat/mouse 38878112
Diabetic atherosclerosis / angiogenesis (loss → increased angiogenesis) in vivo mouse 36200061

⚠️ The human vs. zebrafish IRF3 direction is explicitly contradictory — PMID:37650650 says so directly: "unlike the previous report that zebrafish OTUD6B negatively regulates the antiviral response by suppressing K63-linked ubiquitination of IRF3 and IRF7, we demonstrate that human OTUD6B actually enhances type I IFN response." This is a textbook HUMAN_MODEL_MISMATCH discussion candidate.

6.7 Suggested ontology terms for the pathograph

GO biological process / molecular function — all verified against OLS:

CURIE Label Node
GO:0004843 cysteine-type deubiquitinase activity Loss of OTUD6B DUB activity (MF; modifier: DECREASED)
GO:0016579 protein deubiquitination Loss of OTUD6B DUB activity
GO:0043248 proteasome assembly Impaired 19S→26S proteasome assembly (DECREASED)
GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process Reduced proteasomal degradation (DECREASED)
GO:0034063 stress granule assembly Stress granule dynamics (EMERGING hypothesis)
GO:0002183 cytoplasmic translational initiation mTORC1-coupled translation dysregulation (EMERGING)
GO:0007507 heart development Septation defect node (supported by mouse VSD + human ASD/VSD/ToF)

⚠️ Verify with OAK before use (uv run runoak -i sqlite:obo:go info <ID> -O obo): GO:0031929 TOR signaling; GO:0007420 brain development; GO:0021987 cerebral cortex development; GO:0006915 apoptotic process.

Cell types (CL) — ⚠️ all require OAK verification: CL:2000001 peripheral blood mononuclear cell (the only cell type with direct patient‑derived experimental data) · CL:0000540 neuron · CL:0000127 astrocyte (HPA: "Subsets of astrocytes show general, distinct and intense staining throughout the brain") · CL:0000121 Purkinje cell (HPA: somato‑dendritic staining) · CL:0000746 cardiac muscle cell · CL:0000542 lymphocyte (cytoplasmic inclusions).


7. Anatomical Structures Affected

7.1 Organ level

Primary (directly and consistently affected): - Central nervous system — the dominant organ system. Cortex (ID, seizures, autistic behavior), corpus callosum (hypoplasia 3/12), ventricular system (ventriculomegaly), white matter, with reported cortical atrophy. UBERON:0000955 brain; UBERON:0002336 corpus callosum (verified); UBERON:0000956 cerebral cortex (⚠️ verify); lateral ventricle (⚠️ verify ID). - Musculoskeletal system — hands and feet (broad distal phalanges, tapered fingers, clubfoot, overlapping toes, polydactyly), vertebral column (scoliosis, vertebral anomaly), joints (flexion contractures). - Craniofacial complex — the recognizable gestalt; brachycephaly, flat occiput, retrognathia, high palate, ears (macrotia, low‑set, protruding). - Heart — septal defects (ASD 3/6, VSD 2/6) and conotruncal malformation (Tetralogy of Fallot). Interventricular/interatrial septum are the specific sites; the mouse model independently confirms septation as the vulnerable structure.

Secondary / less consistent: - Gastrointestinal tract (feeding difficulties, chronic constipation) - Genitourinary (cryptorchidism; renal cortical cysts in one blended‑phenotype case) - Thyroid gland (hypothyroidism, ≥3 patients) - Immune system (hypogammaglobulinemia, ≥3 patients) - Eye — optic disc, retina (single case, 2025) - Ear/auditory (hearing impairment) - Teeth/oral (macrodontia, dental crowding, delayed eruption, thick alveolar ridges) - Skin/adnexa (soft doughy skin, hypohidrosis; long eyelashes)

Body systems involved: nervous, cardiovascular, musculoskeletal, digestive, endocrine, immune, genitourinary, integumentary, special senses. This breadth is expected for a defect in a ubiquitously expressed proteostasis enzyme and is why the disorder was framed from the outset as "multisystemic."

7.2 Tissue and cell level

Human Protein Atlas (ENSG00000155100): OTUD6B has low tissue specificity — "Detected in all," tau specificity score 0.24, clustered as "Non-specific — Basic cellular processes." Protein‑level tissue enhancement is noted in cerebral cortex and lymphoid tissue. Within brain, HPA reports immunoreactivity in astrocytes ("Subsets of astrocytes show general, distinct and intense staining throughout the brain"), cerebellar Purkinje cells (somato‑dendritic staining), and choroid plexus cells, across hippocampal formation, cerebral cortex, and cerebellum.

The mouse Otud6b^tm1b^ lacZ reporter independently confirmed near‑ubiquitous expression: per PMC5384096 full text (⚠️ verify), lacZ expression was "nearly ubiquitous" across cardiovascular, nervous, digestive, and musculoskeletal systems.

Implication for curation: there is no evidence for a tissue‑restricted or cell‑type‑restricted primary lesion. The tissue distribution of disease reflects differential vulnerability to proteostasis failure (post‑mitotic neurons, rapidly proliferating embryonic cardiac/limb mesenchyme) rather than restricted gene expression. Model this explicitly rather than implying neural‑specific expression.

7.3 Subcellular level

  • Cytosol (GO:0005829, ⚠️ verify) — HPA reports cytoplasmic localization; primary site of proteasome assembly and translation initiation.
  • Proteasome complex (GO:0000502, ⚠️ verify) / proteasome regulatory particle — the site of the demonstrated 19S assembly defect.
  • Cytoplasmic stress granule (GO:0010494, ⚠️ verify) — demonstrated OTUD6B localization (PMID:41651815).
  • Centrosome and mitotic spindle (⚠️ verify IDs) — "OTUD6B can localise to centrosomes and the mitotic spindle" (PMID:39789388).
  • Cytoplasmic inclusions in patient lymphocytes — a pathological subcellular finding, not a normal compartment.

7.4 Localization and lateralization

Findings are bilateral and symmetric throughout: microcephaly, corpus callosum hypoplasia (a midline structure), bilateral ventriculomegaly ("mild irregular enlargement of the bilateral lateral ventricles," PMID:41188742), symmetric distal limb anomalies of both hands and feet, and midline septal cardiac defects. No lateralized or asymmetric presentation is reported. Note: the bilateral hand+foot involvement pattern makes this a candidate — though not a demonstrated one — for comparison against the limb_digit_patterning_serial_homology module; but OTUD6B is a proteostasis gene, not a limb‑patterning morphogen, so conformance would be phenotypic rather than mechanistic and is not recommended without evidence.


8. Temporal Development

8.1 Onset

  • Antenatal: IUGR (7/12, HPO onset HP:0030674); congenital heart defects detectable prenatally (one family terminated a pregnancy for antenatally diagnosed ToF, PMID:35707595); congenital brain malformations.
  • Neonatal/infantile: hypotonia, feeding difficulties, microcephaly (HPO onset HP:0003593 Infantile onset), nystagmus (detected at 6 months in the Chinese case).
  • Infancy (1–23 months, per GARD): seizures, developmental delay becomes apparent.
  • Onset pattern: congenital / insidious, not acute. There is no asymptomatic interval and no acute presenting crisis.
  • Orphanet records age of onset as infancy.

8.2 Progression

No formal staging system, no natural‑history study, no longitudinal cohort exists. What can be stated:

  • Course: chronic, lifelong. The encephalopathy is best characterized as static/developmental rather than neurodegenerative — imaging findings are malformative (corpus callosum hypoplasia, ventriculomegaly) rather than showing documented progressive loss. (Orphanet's mention of "cortical atrophy" is the one datum pointing the other way; whether it represents progressive atrophy or congenital hypoplasia is unresolved.)
  • Seizures: recurrent/episodic on a chronic background. Refractoriness is implied by PMID:32924626's framing of seizure control as "the current challenge" but has not been systematically reported.
  • Secondary progression: scoliosis, joint contractures, and spastic tetraplegia are expected to progress with growth in the severe group — this is an inference from the phenotype set, not a cited longitudinal finding.
  • Duration: lifelong; no self‑limited component.
  • Remission: none. No spontaneous or treatment‑induced remission of the core phenotype has been reported or would be expected.

8.3 Critical periods

  • Embryonic organogenesis (weeks 4–8): the window during which cardiac septation and limb patterning are established. Both the human cardiac phenotype and the mouse VSD phenotype localize the vulnerability here. No intervention is possible in this window.
  • Fetal/perinatal: the mouse model narrows lethality precisely — homozygotes "survived to E18.5 at expected frequencies," with death occurring between E18.5 and shortly after birth (PMC5384096, ⚠️ verify). This identifies the perinatal transition as the critical survival bottleneck in mice, though human patients survive it.
  • Infancy–early childhood: the only actionable window — for seizure control, feeding support, early intervention/therapy, and detection of the treatable comorbidities (hypothyroidism, hypogammaglobulinemia).

⚠️ Flag: everything in §8.2–8.3 beyond the mouse data is inference. This section is the weakest‑evidenced part of the entity and should carry an explicit KNOWLEDGE_GAP discussion for natural history.


9. Inheritance and Population

9.1 Epidemiology

Measure Value Source
Prevalence <1 / 1,000,000 Orphanet ORPHA:505237
dismech prevalence_class BELOW_1_IN_1000000 derived from Orphanet band
dismech measure_type POINT_PREVALENCE Orphanet convention
rate_per_100000 <0.1 1/1,000,000 → 0.1 per 100,000
Cases in literature ≈28–30 worldwide (2025) PMID:41188742 (verbatim: "There have been < 30 reported cases globally…"); the 2025 paper's Table 1 tabulates 27 previously reported cases + 1 index = 28
Incidence Not established

An alternative dismech Prevalence record with measure_type: CASES_IN_LITERATURE and rate_per_100000 omitted would faithfully capture the ~28‑case count; use the Orphanet band for the population rate.

9.2 Genetic epidemiology

  • Inheritance pattern: Autosomal recessive (HP:0000007). Confirmed by ClinGen Definitive curation (AR), OMIM, Orphanet, and segregation in every reported family (both parents heterozygous carriers). GARD states the standard recurrence figures: "there is a 25% chance their child will have the disease and a 50% chance the child will be a carrier."
  • Penetrance: appears complete for biallelic pathogenic genotypes. No unaffected biallelic individual has been reported. However, with n≈30 and complete ascertainment bias toward affected probands, non‑penetrance for hypomorphic genotypes cannot be excluded — a mildly affected biallelic adult would very likely never be sequenced.
  • Expressivity: highly variable, both between and within families (PMID:34354232: "our patients showed inter- and intrafamilial differences with regard to the clinical and brain imaging findings"). Genotype accounts for much but not all of the variance (§3.3).
  • Genetic anticipation: not applicable — no repeat expansion mechanism.
  • Germline mosaicism: not reported; recurrence risk counselling should follow standard AR (25%) figures.
  • Founder effects: none formally established. c.433C>T (p.Arg145*) recurs in three of the six original families and in the Mexican proband — worth a haplotype study, but published as independent occurrences (a CpG→TpG transition at an arginine codon is a recurrent‑mutation hotspot signature, which is at least as parsimonious as a founder haplotype). Do not assert a founder effect.
  • Consanguinity: the dominant epidemiological driver. Homozygous genotypes predominate; families are reported from Turkey, Egypt (two unrelated consanguineous families), the Gulf/Saudi region, Mexico, Spain, Italy, and China. PMID:34354232 draws the methodological conclusion directly: "demonstrating the need for in-depth analysis of WES data in consanguineous families to uncover simultaneous autosomal recessive disorders."
  • Carrier frequency: not established. gnomAD LOEUF 1.48 / pLI 0 indicates pLoF alleles are present in the population at low frequency, but no carrier‑frequency estimate has been published. Reported disease alleles are absent or <10⁻⁵ in gnomAD.

9.3 Population demographics

  • Affected populations: no ethnic group has a demonstrated elevated prevalence. The apparent concentration in Middle Eastern, North African, Mediterranean, and Latin American reports reflects consanguinity rates and access to exome sequencing, not a population‑specific allele.
  • Geographic distribution: worldwide; reported from Europe (Italy, Spain), Middle East/North Africa (Turkey, Egypt, Saudi Arabia), the Americas (Mexico, USA), and East Asia (China — first case only in 2025).
  • Variant geography: no variant is geographically restricted in a way that establishes a founder allele.
  • Sex ratio: expected 1:1 (autosomal). Reported cases include both sexes with no documented skew; n is too small for a meaningful ratio.
  • Age distribution: the reported population is overwhelmingly pediatric (infants through school age). There are essentially no published adult patients, which is itself an information gap — it is unknown whether this reflects reduced survival, diagnostic ascertainment bias toward children in the exome era, or both.

10. Diagnostics

10.1 Clinical tests

There is no biochemical screening test, no biomarker, and no functional assay in clinical use for this disorder. Diagnosis is molecular. Supporting/complication‑detection investigations:

Modality Finding Purpose
Brain MRI Corpus callosum hypoplasia, ventriculomegaly, white‑matter abnormalities, cortical atrophy; "mild irregular enlargement of the bilateral lateral ventricles" (PMID:41188742) Characterize structural CNS involvement; supports the diagnosis but is non‑specific
EEG Required for seizure characterization No OTUD6B‑specific EEG signature has been described
Echocardiography ASD, VSD, Tetralogy of Fallot Mandatory at diagnosis — CHD in ~33–50%
Thyroid function tests (TSH, fT4) Hypothyroidism in ≥3 patients PMID:32924626 explicitly recommends screening: "underscoring the value of screening for these conditions in other patients"
Serum immunoglobulins (IgG, IgA, IgM) Hypogammaglobulinemia in ≥3 patients Same recommendation
Ophthalmological exam incl. fundoscopy Optic disc hypoplasia, retinal abnormalities, nystagmus (1 case) Newly recommended by PMID:41188742
Audiological assessment Hearing impairment (HPO‑annotated) Standard for syndromic ID
Spine radiographs Scoliosis, vertebral anomaly Surveillance
Renal ultrasound Cortical cysts (1 case, confounded by PKD1) Consider
Growth monitoring IUGR, short stature, failure to thrive Ongoing

Research‑only cellular assays (not clinically available, but of high mechanistic value — and the basis of any future functional‑evidence framework for VUS interpretation): - Native PAGE of PBMC lysates for 19S/26S proteasome assembly (Rpn5, Rpt6 incorporation) - 26S chymotrypsin‑like peptidase activity assay - Anti‑ubiquitin immunoblot for ubiquitin‑protein conjugate accumulation - Light microscopy for cytoplasmic lymphocyte inclusions

Biopsy/histopathology: no diagnostic biopsy indicated; no characteristic histopathology described beyond the lymphocyte inclusions.

No LOINC‑coded disease‑specific test exists.

10.2 Genetic testing — the diagnostic route

Recommended approach: trio exome or genome sequencing, with parallel or reflex chromosomal microarray.

Modality Utility Notes
Trio WES First‑line; highest yield. Every published diagnosis except one was made by exome sequencing PMID:41188742 used "TrioWES"; PMID:34680978, 35430327, 35707595, 32924626, 30364145 all WES
WGS Useful when WES is negative but suspicion is high Would capture deep‑intronic and structural events; no published OTUD6B case required WGS
Chromosomal microarray (CMA) Essential adjunct, not optional. One reported case required CMA to find the second allele — a 0.118 Mb 8q21.3 deletion in trans with a point mutation (PMID:34680978) A WES‑only workflow would have reported this patient as a heterozygous carrier and missed the diagnosis
Gene panels OTUD6B is included on broad ID/epileptic‑encephalopathy/NDD panels Panel content varies; confirm inclusion
Single‑gene testing Justified only for targeted familial testing or where the clinical gestalt is strongly recognizable in a consanguineous family — PMID:34354232's Family II used "targeted sequencing" after clinical suspicion Not a first‑line strategy
RNA studies (RT‑PCR / competitive‑fluorescent RT‑PCR) High value for splice variants. The single best functional evidence in the literature (PMID:30364145) came from patient‑RNA quantification Should be pursued for any canonical or near‑splice VUS
Karyotyping / FISH No role — the reported deletion (0.118 Mb) is far below karyotype resolution
mtDNA testing No role
Repeat expansion testing No role

Critical WES‑interpretation caveat, twice demonstrated: in consanguineous families, a second homozygous recessive disorder may coexist and confound phenotyping. PMID:34354232 found homozygous RP1L1 nonsense variants explaining retinal degeneration that had initially been attributed to OTUD6B; PMID:35707595 found a heterozygous PKD1 variant explaining renal cysts. Do not attribute every feature in a proband to OTUD6B without checking the rest of the exome.

10.3 Omics‑based diagnostics

  • RNA‑seq / transcriptomics: not in clinical use for this disorder; targeted RT‑PCR for splice variants is the practical alternative (§10.2).
  • Proteomics: research only. Note that proximity proteomics (BioID‑style) was the discovery method for the OTUD6B–VCP interaction (PMID:41651815).
  • Metabolomics / lipidomics: no signature described. No data available.
  • Epigenomics: no episignature published. Given demonstrated Kabuki‑syndrome mimicry, an OTUD6B episignature would be a high‑value diagnostic development — currently a gap, not a resource.
  • Liquid biopsy: not applicable.

10.4 Clinical criteria and differential diagnosis

No formal consensus diagnostic criteria exist (no society guideline, no DSM/ICD operational criteria, no GeneReviews chapter as of this review). Diagnosis = compatible phenotype + biallelic pathogenic OTUD6B variants.

A clinically recognizable gestalt is claimed but contested. PMID:38389298 puts it precisely: "Physical differences described for affected individuals suggest that the disorder may be clinically recognizable, but previous publications have reported an initial clinical suspicion for Kabuki syndrome (KS) in some affected individuals." The most specific reported sign is from PMID:34354232 — broad distal phalanges of thumbs and halluces with prominent interphalangeal joints and persistent fetal pads, described as "pathognomonic." (⚠️ "Pathognomonic" is the authors' assertion from a 5‑patient, 2‑family series; treat as a strong clinical pearl, not an established specificity claim.)

Differential diagnosis — each entry below is grounded in an actual published misdiagnosis or clinical suspicion, which makes this an unusually well‑evidenced DDx:

Condition Overlapping features Discriminator
Kabuki syndrome (KMT2D, KDM6A) Long palpebral fissures, prominent/cupped ears, persistent fetal fingertip pads, DD, growth deficiency, vertebral anomaly, seizures — documented initial clinical diagnosis in ≥2 reports (PMID:38389298, PMID:30364145) Inheritance (KS is AD/XL vs. AR); KMT2D/KDM6A episignature; eversion of the lower lateral eyelid
Rubinstein–Taybi syndrome (CREBBP, EP300) Broad thumbs and halluces, ID, dysmorphism — the Italian proband "came to our attention after being screened for genes responsible for Rubinstein-Taybi syndrome" (PMID:30364145) AD vs. AR; RTS broad thumbs are typically angulated; PMID:30364145 explicitly recommends screening OTUD6B in RTS‑suspected, RTS‑gene‑negative patients
Williams–Beuren syndrome (7q11.23 del) Periorbital edema, hanging cheek, long smooth philtrum, cardiac defect, DD — "facial phenotypes resembling Williams syndrome" (PMID:34680978) CMA; supravalvar aortic stenosis; hypercalcemia; social phenotype
ZMIZ1‑related NDD ID, facial dysmorphism, distal limb anomalies, seizures — PMID:34680978 notes "shared phenotypes of facial dysmorphism, distal limb anomalies, and seizure disorders" AD vs. AR
Cornelia de Lange syndrome IUGR, microcephaly, limb anomalies, ID, arched eyebrows, long eyelashes Synophrys; upper‑limb reduction defects; cohesinopathy genes
Other proteostasis/DUB NDDs — OTUD7A (15q13.3), and proteasome‑associated disorders ID + epilepsy + DUB/UPS mechanism Gene identity; OTUD7A is AD/CNV‑driven at 15q13.3
Other AR syndromic ID with seizures (broad category) Overlapping core Requires ES/GS

10.5 Screening

  • Newborn screening: not included in any NBS panel; no biochemical marker exists to enable it. Notably, the Chinese proband's hypothyroidism was detected on routine newborn metabolic screening — an incidental route to earlier attention, not a screen for the disorder itself.
  • Carrier screening: OTUD6B is included in some expanded carrier‑screening panels (⚠️ panel‑dependent; verify with GTR before asserting). Justified in consanguineous couples and in families with an affected relative.
  • Cascade screening: standard AR cascade — test at‑risk siblings and offer carrier testing to relatives once the familial variants are known.
  • Prenatal / preimplantation: available once both familial variants are characterized (see §13).

11. Outcome / Prognosis

⚠️ This section is the most evidence‑poor in the report. There is no survival study, no mortality figure, no life‑expectancy estimate, no disability‑outcome measure, and no validated prognostic model for OTUD6B‑related disorder. What follows distinguishes the few citable facts from clinical inference.

11.1 Survival and mortality

  • Human survival data: none published. No 5‑year or 10‑year survival figure, no mortality rate, no disease‑specific mortality estimate exists. The published cohort is pediatric and cross‑sectional.
  • The published population contains essentially no adults, which is itself the only survival‑adjacent signal — and it is confounded by the recency of the gene discovery (2017) and by exome‑era ascertainment favoring children.
  • Mouse mortality is severe and well‑characterized, but does not transfer to humans: homozygous Otud6b knockouts are subviable with near‑complete perinatal lethality (MGI: "complete perinatal lethality"; PMC5384096: only 2 of 97 births, p<1×10⁻⁵, both died at birth). Human patients with predicted‑null biallelic genotypes survive infancy, so the mouse null overstates human lethality. This is a genuine HUMAN_MODEL_MISMATCH — model it as such, not as a survival prediction.
  • Expected principal mortality contributors, by analogy with comparable severe syndromic encephalopathies (inference, uncited): aspiration/respiratory infection in feeding‑tube‑dependent non‑ambulatory patients; complications of congenital heart disease; status epilepticus.

11.2 Morbidity and function

  • Severe group: profound functional impairment — non‑verbal, non‑ambulatory ("inability to walk"), spastic tetraplegia, total care dependence, gastrostomy feeding. ICF‑level disability is severe across mobility, communication, and self‑care domains.
  • Mild group: mild‑to‑moderate ID with preserved speech and ambulation; substantially better functional prognosis.
  • No QoL instrument has been applied (no EQ‑5D, SF‑36, PROMIS, or disease‑specific PROM). See §3.3.

11.3 Complications

Documented: recurrent seizures; feeding failure and aspiration risk; failure to thrive/short stature; congenital heart disease and its sequelae; progressive scoliosis and contractures; hypothyroidism; hypogammaglobulinemia (with attendant infection risk); hearing impairment; visual impairment (single case); constipation.

Recovery potential: none for the core neurodevelopmental phenotype. Developmental gains occur but the underlying encephalopathy is not reversible with any current intervention. Treatable comorbidities (hypothyroidism, seizures, CHD, nutrition) are the domains where intervention changes outcome.

11.4 Prognostic factors

The only supported prognostic factor is genotype severity class: - Biallelic predicted‑null (nonsense/frameshift/canonical splice, both alleles) → severe phenotype - Hypomorphic missense or leaky splice on ≥1 allele → milder phenotype

PMID:35430327 formalized this with molecular‑dynamics modelling: p.Tyr216Cys (mild) → "localized destabilization"; p.Ile274Arg (severe) → "significant distortion in the overall fold of OTUD6B." Its own conclusion is appropriately hedged: "However, additional functional studies are required."

Additional plausible but unvalidated prognostic markers: presence/severity of microcephaly; age at seizure onset and seizure control; presence of CHD; degree of structural brain malformation on MRI. None is validated.

Prognostic biomarkers: none. The proteasome‑assembly assay is a candidate quantitative severity readout (given the observed WT < het < hom gradient) but has never been correlated with clinical outcome. This is a concrete, tractable research proposal worth recording as a proposed_experiments item.


12. Treatment

There is no disease‑modifying, targeted, or curative therapy for OTUD6B‑related neurodevelopmental disorder. Management is entirely symptomatic, supportive, and anticipatory. No clinical trial has ever been registered for this disorder (ClinicalTrials.gov search: no OTUD6B‑specific trials). No FDA/EMA‑approved therapy exists. No pharmacogenomic guidance (CPIC/PharmGKB: zero high‑level records for OTUD6B, per ClinGen).

The literature contains no treatment protocol; the closest statement of intent is PMID:32924626: "The current challenge with this patient is to ensure medical management of his seizures and provide him with a better quality of life. The possibilities of additional therapeutic approaches may increase by understanding the physiopathology of the involved pathways."

12.1 Management components with suggested NCIT terms

⚠️ All NCIT IDs below require verification (uv run runoak -i sqlite:obo:ncit info <ID> and just validate-terms). They are supplied as curation candidates, not verified bindings. Treatments in this section are standard‑of‑care inferences for syndromic ID with epilepsy, not OTUD6B‑specific published recommendations — this must be stated explicitly in any KB entry.

Intervention treatment_term (NCIT, ⚠️ verify) therapeutic_modality Basis
Antiseizure medication NCIT:C15986 Pharmacotherapy SMALL_MOLECULE Universal (seizures 12/12). No agent‑specific data; no evidence any ASM class is preferentially effective. therapeutic_agent should be left generic unless a specific drug is documented per patient.
Levothyroxine replacement NCIT:C15986 Pharmacotherapy SMALL_MOLECULE For the documented hypothyroidism subgroup (PMID:32924626, PMID:41188742). therapeutic_agent: levothyroxine (CHEBI, ⚠️ verify)
Immunoglobulin replacement NCIT:C15986 Pharmacotherapy OTHER/PROTEIN_REPLACEMENT Consider for symptomatic hypogammaglobulinemia (PMID:32924626). ⚠️ No published case reports IVIG use — this is inference.
Cardiac surgical repair (septal defect closure; ToF repair) NCIT:C15329 Surgical Procedure SURGERY CHD in 33–50%; ToF documented (PMID:35707595)
Gastrostomy / enteral feeding NCIT:C15747 Supportive Care or NCIT:C15433 Nutritional Support OTHER Feeding tubes explicitly required in the severe group (MedGen/OMIM summary)
Physical therapy NCIT:C15302 Physical Therapy BEHAVIORAL Hypotonia, contractures, non‑ambulation
Occupational therapy NCIT:C121351 Occupational Therapy BEHAVIORAL Fine motor, ADLs
Speech and language therapy / AAC NCIT:C159273 Speech Therapy BEHAVIORAL Absent or delayed speech
Orthopedic management of scoliosis/contractures (bracing, corrective surgery) NCIT:C16186 Orthopedic Surgical Procedure SURGERY Scoliosis 5/12
Hearing aids / audiological management (no reliable NCIT action term — see CLAUDE.md note) DEVICE Hearing impairment HPO‑annotated
Ophthalmological / low‑vision management NCIT:C49236 Therapeutic Procedure Nystagmus, optic disc hypoplasia (1 case)
Genetic counseling NCIT:C15240 Genetic Counseling AR 25% recurrence; consanguinity counselling
Early intervention / developmental services NCIT:C15315 Rehabilitation BEHAVIORAL Standard for syndromic ID

12.2 Advanced therapeutics — status

Modality Status
Gene therapy (AAV gene replacement) None. Not in preclinical development. OTUD6B's small coding sequence (293 aa, ~882 bp) makes it AAV‑tractable in principle, but the disorder's largely prenatal/early‑developmental onset makes postnatal CNS gene replacement of uncertain benefit.
Gene editing None
RNA therapeutics (ASO/siRNA) None. Notably, the two splice alleles (c.324+1G>C, c.405+1G>A) are the type of lesion sometimes amenable to splice‑switching ASO, but no such program exists and the residual‑transcript data (<1% WT) suggest an already‑near‑null substrate.
Cell therapy None
Targeted small molecules None. OTU‑family DUB inhibitors are an active drug‑discovery area (PMID:40527635), but that pipeline aims at inhibiting OTU DUBs in cancer — the opposite of what a loss‑of‑function disorder requires. Do not curate OTU‑targeting oncology therapeutics as candidate treatments for this disease.
Proteostasis modulation Conceptually attractive (a proteasome‑assembly chaperone or activator) but entirely hypothetical; no agent identified.
Immunotherapy Not applicable

12.3 Treatment outcomes, adverse events, algorithms

  • Response rates: no data. No treatment has been formally evaluated in this disorder.
  • Adverse events: no disorder‑specific safety signal reported. No published contraindication or pharmacogenomic interaction.
  • Treatment algorithms / clinical pathways: none published; no NCCN/society guideline. Care should follow generic multidisciplinary syndromic‑ID pathways.
  • Combination therapy / personalized medicine: not applicable at present. The only genotype‑informed element of care is prognostic counselling based on the null‑vs‑hypomorph severity split (§11.4).

12.4 Actionable, evidence‑based surveillance recommendation

The single most useful management statement in the literature is the screening recommendation from PMID:32924626, which should be carried into the KB entry:

In addition to seizures and other more frequently reported manifestations of this condition, this is the third patient with associated hypothyroidism and hypogammaglobulinemia, underscoring the value of screening for these conditions in other patients.

To which PMID:41188742 adds ophthalmological evaluation. Baseline workup at diagnosis should therefore include: echocardiogram, brain MRI, EEG, thyroid function tests, serum immunoglobulins, ophthalmological examination with fundoscopy, audiology, and spine imaging.


13. Prevention

Because this is a fully penetrant monogenic recessive disorder with no environmental component, prevention means reproductive genetics — not risk‑factor modification.

13.1 Primary prevention

  • Not achievable by any behavioral, dietary, environmental, or public‑health intervention. There is no modifiable risk factor.
  • Genetic counseling is the primary preventive intervention. NCIT:C15240 (⚠️ verify). For carrier couples: 25% recurrence per pregnancy, 50% carrier, 25% unaffected non‑carrier (GARD).
  • Preconception carrier screening, particularly in consanguineous couples and in communities with high consanguinity rates, is the highest‑yield population‑level measure.
  • Preimplantation genetic testing for monogenic disease (PGT‑M) and prenatal diagnosis (CVS/amniocentesis) are available once both familial variants are molecularly characterized. These are the only interventions that prevent occurrence.

13.2 Secondary prevention (early detection)

  • Cascade testing of siblings and at‑risk relatives after a proband diagnosis.
  • Early molecular diagnosis of a symptomatic infant — the practical benefit is not disease modification but (a) ending the diagnostic odyssey, (b) triggering the surveillance protocol in §12.4, and (c) enabling accurate recurrence counselling before the next pregnancy.
  • Note the incidental‑detection route: the Chinese proband's hypothyroidism was picked up on routine newborn metabolic screening, which brought her to medical attention at 6 months.
  • No population screening program exists or is proposed, and none is justified at a prevalence of <1/1,000,000 with no presymptomatic treatment.

13.3 Tertiary prevention (preventing complications in diagnosed patients)

This is where prevention is genuinely actionable: - Systematic screening for hypothyroidism and hypogammaglobulinemia (explicitly recommended, PMID:32924626) — both are treatable and both, if missed, add avoidable morbidity. - Echocardiography at diagnosis to detect surgically correctable CHD. - Ophthalmological and audiological assessment to prevent avoidable sensory‑deprivation contributions to developmental delay. - Aspiration prevention via feeding assessment and, where indicated, gastrostomy. - Scoliosis and contracture surveillance with early orthopedic and physiotherapy intervention. - Seizure control optimization.

13.4 Not applicable

  • Immunization: no disease‑specific vaccine strategy. (Standard childhood immunization applies; if hypogammaglobulinemia is present, live‑vaccine caution and immunological input follow standard immunodeficiency practice — ⚠️ inference, not published for this disorder.)
  • Public‑health / environmental interventions: not applicable.
  • Chemoprophylaxis: none, unless antimicrobial prophylaxis is indicated for a documented antibody deficiency (⚠️ inference).

14. Other Species / Natural Disease

14.1 Taxonomy and orthologs

Species NCBI Taxon Gene Identifier Notes
Homo sapiens NCBITaxon:9606 OTUD6B Entrez 51633; HGNC:24281 8q21.3; 293 aa
Mus musculus NCBITaxon:10090 Otud6b MGI:1919451 Chr4: 14,809,503–14,826,413 (minus strand); ortholog of human chr8:91,070,196–91,087,095
Danio rerio NCBITaxon:7955 otud6b ZFIN (⚠️ verify ID) Functional antiviral studies (PMID:34183367)
Rattus norvegicus NCBITaxon:10116 Otud6b RGD (⚠️ verify ID) Used in PAH studies (PMID:38878112)

⚠️ Caution: MGI:1922805 is not Otud6b (it is Nsmce3l). Use MGI:1919451.

14.2 Natural disease in other species

None reported. There is no naturally occurring OTUD6B‑related disease in any companion animal, livestock species, or wildlife population. A search of the veterinary literature and OMIA yields no OTUD6B entry (⚠️ OMIA was not directly queried in this review — verify at omia.org before asserting absence definitively).

Veterinary relevance: none. All animal OTUD6B disease models are experimentally induced, not natural.

14.3 Comparative biology

  • Evolutionary conservation: OTUD6B is conserved across vertebrates, with functional orthologs demonstrated in mouse, rat, and zebrafish. The OTU catalytic domain and its cysteine‑protease triad are the deeply conserved elements.
  • Comparative pathology — a key mismatch. The mouse null is substantially more severe than the human null: homozygous Otud6b^tm1b/tm1b^ mice are subviable with essentially complete perinatal lethality, whereas human patients with biallelic predicted‑null alleles survive into childhood. Conversely, the cardiac phenotype is strikingly concordant — mouse VSD at high penetrance vs. human ASD/VSD/ToF — making the heart the best cross‑species‑validated organ.
  • Direction‑of‑effect divergence in innate immunity: the human vs. zebrafish IRF3 results are explicitly opposite (§6.6). This is a documented species divergence, not merely an unreplicated result, and should be curated as HUMAN_MODEL_MISMATCH rather than as conflicting evidence for a single claim.
  • Transmission / zoonosis / cross‑species susceptibility: not applicable — this is a germline monogenic disorder.

15. Model Organisms

15.1 Mouse — the principal disease model

Allele: Otud6b^tm1b(EUCOMM)Wtsi (MGI:5637064) — a knockout‑first tm1a converted to tm1b by Cre‑mediated excision of the promoter‑driven neo cassette and critical exon(s), leaving a lacZ reporter in place. This design is what enabled the expression mapping.

Repositories: MGI records 10 mutations/alleles for Otud6b (2 endonuclease‑mediated, 4 gene‑trapped, 4 targeted) and 29 strains/lines available through IMSR. A line is archived at MRC Harwell (B6Dnk;B6N-Otud6b^tm1b(EUCOMM)Wtsi/WtsiCnbc, stock 7042). IMPC phenotyping data at mousephenotype.org/data/genes/MGI:1919451.

Phenotype (MGI summary): "complete perinatal lethality, decreased fetal size, and ventricular septal defects," with annotations spanning cardiovascular, growth/size, hematopoietic, immune, and mortality/aging systems, from 13 phenotype references.

Detailed findings (PMC5384096 full text — ⚠️ paraphrase‑risk, verify before use as snippets): - Subviability: only 2 homozygotes identified from 97 births (p<1×10⁻⁵ deviation from Mendelian expectation); both died at birth. - Timing of lethality: homozygotes survived to E18.5 at expected frequencies → death occurs between E18.5 and shortly after birth. This is a precise and useful window. - Growth: E18.5 knockout embryos showed 34% reduced total volume vs. wild‑type littermates — a direct correlate of the human IUGR/growth restriction phenotype. - Cardiac: ventricular septal defects in 80% of hearts (3/3 at E14.5; 1/2 at E18.5) vs. a 0.67% background rate in C57BL/6N controls. - Expression: lacZ reporter expression "nearly ubiquitous," across cardiovascular, nervous, digestive, and musculoskeletal systems.

IMPC phenotyping (mousephenotype.org, MGI:1919451): 2 significant phenotypes; 3 of 21 tested physiological systems significantly impacted — mortality/aging, immune system, hematopoietic system (18 systems no significant impact, 3 not tested). Note that the immune and hematopoietic hits are independently interesting given the human hypogammaglobulinemia reports and the B‑lymphocyte cell‑cycle work (PMID:21267069).

15.2 Phenotype recapitulation and limitations

Human feature Mouse recapitulation Assessment
Congenital heart disease (ASD/VSD/ToF) VSD in 80% of hearts vs. 0.67% background Excellent — strongest cross‑species validation
Growth restriction / IUGR 34% reduced embryo volume at E18.5 Good
Immune involvement (hypogammaglobulinemia) IMPC significant immune + hematopoietic impact Suggestive
Intellectual disability Not assessable — homozygotes die perinatally Not recapitulated
Seizures Not assessable — perinatal lethality Not recapitulated
Microcephaly / brain malformation Not reported Not recapitulated / not examined
Survival Perinatal lethal in mouse; survival to childhood in humans Direct mismatch

Limitations — this is the crux of the model problem and should be curated as an explicit HUMAN_MODEL_MISMATCH discussion:

The constitutive mouse null is too severe to model the defining features of the human disease. Because homozygotes die at birth, the model cannot address intellectual disability, seizures, speech, ambulation, microcephaly, or any postnatal neurodevelopmental outcome — i.e., the entire clinical core of IDDFSDA. What the mouse does establish is the embryonic arm: cardiac septation and fetal growth. The human null phenotype is milder than the mouse null, meaning there is either species‑specific redundancy (possibly OTUD6A or other OTU‑family paralogs) or a difference in developmental dependence on the enzyme.

Proposed experiments to resolve the mismatch (proposed_experiments candidates): 1. Conditional/neural‑specific Otud6b knockout (e.g., Nestin‑Cre, Emx1‑Cre) to bypass perinatal lethality and interrogate cortical development, seizure susceptibility, and behavior. 2. Hypomorphic knock‑in of the human missense alleles (p.Tyr216Cys as the "mild" allele; p.Ile272Arg/p.Ile274Arg as the "severe" allele) to test the genotype–severity model computationally proposed by PMID:35430327 in an in‑vivo system. 3. Patient iPSC‑derived cortical neurons and cerebral organoids — currently the most important missing model. No iPSC or organoid model of OTUD6B deficiency has been published. This would permit direct testing of the proteasome‑assembly defect in human neurons and of the mTORC1‑translation and stress‑granule hypotheses in the disease‑relevant cell type. 4. Correlate the PBMC proteasome‑assembly assay with clinical severity across a genotype‑stratified patient cohort, to test whether it functions as a quantitative severity biomarker.

15.3 Other model systems

System Use Relevance to IDDFSDA PMID
Zebrafish otud6b mutant/KO Antiviral innate immunity (irf3/irf7 K63‑Ub) Low — immune, not neurodevelopmental; and direction of effect conflicts with human 34183367
Rat (PAH model) Calpain‑1/HIF‑1α in pulmonary hypertension Low 38878112
Mouse Ba/F3 cells + primary B lymphocytes Cell‑cycle G1 arrest; TTP‑mediated mRNA destabilization Moderate — cell‑cycle mechanism 21267069
Human cancer cell lines (NSCLC, HCC, TNBC, MM, CRC, ESCC, cholangiocarcinoma) Translation, pVHL/HIF, KIFC1/centrosome, LIN28B/MYC, stress granules Mechanistically informative but disease‑context‑mismatched. All are IN_VITRO and none models neurodevelopment. Curate with evidence_source: IN_VITRO and explicitly note the context mismatch. 27864334, 32328410, 39789388, 36059274, 41651815
Patient PBMCs 19S/26S proteasome assembly, chymotrypsin‑like activity, Ub‑conjugate accumulation Highest relevance — the only patient‑derived functional system, and the source of the disease's core mechanism 28343629
iPSC / organoid None published. Major gap.
Drosophila / C. elegans / yeast No published OTUD6B‑ortholog disease model

Model databases: MGI (informatics.jax.org/marker/MGI:1919451), IMPC (mousephenotype.org/data/genes/MGI:1919451), IMSR (29 strains), EUCOMM/EMMA, MRC Harwell (stock 7042), ZFIN, RGD, Alliance of Genome Resources.


Consolidated Evidence Register

References with verbatim abstracts captured in this report (suitable for snippet: after just fetch-reference + just validate-references):

PMID Year Type Role evidence_source
28343629 2017 AJHG, original series (n=12/6 families) Landmark — disease definition, variants, mouse, proteasome mechanism HUMAN_CLINICAL (+ MODEL_ORGANISM, IN_VITRO for sub-claims — split the item)
30364145 2018 Front Genet, case First independent replication; RT‑PCR splice functional data; Rubinstein‑Taybi DDx HUMAN_CLINICAL
31147255 2020 An Pediatr, case First Spanish case (Spanish‑language; no English abstract — cached record has no abstract text; do not fabricate a snippet) HUMAN_CLINICAL
32181568 2020 AJMG A, commentary Alkuraya comment on the AJHG paper (no abstract — cache confirms content_type: abstract_only with no abstract body; unusable as a snippet source)
32924626 2020 JIMCRI, case First Mexican case; hypothyroidism + hypogammaglobulinemia screening recommendation HUMAN_CLINICAL
34354232 2022 J Hum Genet, 5 patients/2 families Egyptian families; orodental features; "pathognomonic" fetal pads; RP1L1 exclusion HUMAN_CLINICAL
34680978 2021 Genes, case Point mutation + 0.118 Mb 8q21.3 microdeletion; Williams‑like features; ZMIZ1 co‑occurrence HUMAN_CLINICAL
35430327 2022 EJMG, case + modelling Genotype–severity structural/MD modelling (Tyr216Cys vs Ile274Arg) HUMAN_CLINICAL + COMPUTATIONAL (split)
35707595 2022 Mol Syndromol, case Tetralogy of Fallot; p.Ile272Arg; PKD1 blended phenotype HUMAN_CLINICAL
38389298 2024 AJMG A, 3 siblings Kabuki syndrome mimicry; delayed dentition, hypohidrosis, mirror movements HUMAN_CLINICAL
41188742 2025 BMC Pediatr, case First Chinese case; ocular dysplasia; 28‑case tabulation; "<30 reported cases globally" HUMAN_CLINICAL
27864334 2017 Mol Cancer Res mTORC1‑downstream translation; isoform antagonism; cyclin D1/c‑Myc IN_VITRO
21267069 2011 PLoS One First functional characterization; Cys‑dependent DUB activity; G1 arrest; TTP regulation IN_VITRO + MODEL_ORGANISM
36059274 2022 EMBO J OTUD6B–LIN28B–MYC axis; G1/S IN_VITRO
39789388 2025 EMBO Rep KIFC1/centrosome clustering; catalytic‑activity dependence IN_VITRO
41651815 2026 Cell Death Dis Stress granules + VCP/p97; most neurologically suggestive recent mechanism IN_VITRO
32328410 2020 Adv Sci Enzyme‑independent pVHL stabilization; HIF‑1α feedback loop IN_VITRO
33421002 2021 Methods Mol Biol First direct OTUD6B–OTUB1 interaction IN_VITRO
34183367 2021 J Immunol Zebrafish otud6b, negative antiviral regulator MODEL_ORGANISM
37650650 2023 mBio Human OTUD6B, positive antiviral regulator via IRF3 K33‑Ub — explicit contradiction with zebrafish IN_VITRO + MODEL_ORGANISM
35662507 2022 Biol Psychiatry, review "The DUB Club" — DUBs and NDDs framing OTHER
40527635 2026 Trends Mol Med, review OTU DUBs in disease and their targeting OTHER

Structured‑database citations available: ORPHA:505237 (Orphanet — definition, prevalence <1/1,000,000, ICD‑10 Q87.8, AR inheritance, infancy onset) and a CGGV: ClinGen gene‑disease validity record (OTUD6B / syndromic intellectual disability / AR / Definitive / ID and Autism GCEP / 2024‑08‑22). Both should be pulled through the repo's structured‑source pipeline (just structured-rebuild-orphanet --id 505237, just clingen-refresh + just clingen-list) rather than hand‑transcribed.


Prioritized Knowledge Gaps

  1. No natural history study. Survival, life expectancy, adult outcomes, and progression rate are entirely unknown. There are effectively no published adult patients.
  2. No iPSC / cortical organoid model. The mouse null's perinatal lethality means the human disease's defining features (ID, seizures, microcephaly) have never been modelled in any system. This is the single largest mechanistic gap. → HUMAN_MODEL_MISMATCH.
  3. The link from proteasome dysfunction to the neural phenotype is unestablished. The 19S assembly defect is demonstrated in PBMCs; nothing connects it to cortical development, neuronal excitability, or seizure generation. The mTORC1‑translation and stress‑granule/VCP routes are plausible bridges but are EMERGING hypotheses from non‑neuronal cells.
  4. Direction of effect on neural progenitor proliferation is unknown — OTUD6B is anti‑proliferative in one system and pro‑proliferative in another. Is microcephaly proliferative or apoptotic in origin?
  5. No episignature, despite documented Kabuki‑syndrome mimicry — a tractable diagnostic development.
  6. HPOA frequencies derive from a single, severity‑biased 12‑person cohort and conflict with later mild cases (e.g., "Severe intellectual disability 12/12").
  7. The proteasome‑assembly assay has never been correlated with clinical severity despite showing a clean WT<het<hom gradient — an obvious candidate quantitative biomarker.
  8. Genotype–severity model is computational only (PMID:35430327's own caveat: "additional functional studies are required"), and intrafamilial variability argues that genotype is not the whole story.

Sources

Literature (PubMed): PMID:28343629 · PMID:30364145 · PMID:31147255 · PMID:32181568 · PMID:32924626 · PMID:34354232 · PMID:34680978 · PMID:35430327 · PMID:35707595 · PMID:38389298 · PMID:41188742 · PMID:27864334 · PMID:21267069 · PMID:36059274 · PMID:39789388 · PMID:41651815 · PMID:32328410 · PMID:33421002 · PMID:34183367 · PMID:37650650 · PMID:35662507 · PMID:40527635 · PMC5384096 (AJHG full text) · PMC12584513 (BMC Pediatr full text)

Databases and aggregators: OMIM #617452 · OMIM *612021 · Orphanet ORPHA:505237 · MedGen C4479520 · GARD 17942 · HPO annotations (ontology.jax.org) · ClinGen OTUD6B (HGNC:24281) · HGNC REST (OTUD6B) · UniProt Q8N6M0 · Human Protein Atlas ENSG00000155100 · MGI:1919451 (mouse Otud6b) · MGI:5637064 (Otud6b tm1b allele) · IMPC MGI:1919451 · MRC Harwell stock 7042 · ClinVar and PubMed queried via NCBI E‑utilities · OLS4 (EBI) for GO/UBERON/MONDO verification